ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000704.1|Kanamycin_1 # 1 # 1014 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0000704.1|Kanamycin_1 	1	1014	+	Loose	660	32.7278	MexS	40.0	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCAGCCGCGCGATCGTCGTCGAGCGGCCCGGCGCACACCGCCTGGTCACCCGGGGCACCCCCACCCCCGGCCCCGGCGAGGTCCTCGTCCGCGTGGCCGCCGCGGGCATCTGCGGGAGCGACCGCGAGGTGTACGACGGACACCGCGACGCCGCGTACGTGCGCTACCCCGTGATCCCCGGCCACGAGTGGTCGGGGACCGTCGCTGCGGTCGGCGAGGGCGTCGACCCCGGGCTGCTCGGGCGCAGGACCGTCGCCGAGGGGTTCCGGGCGTGCGGTGTCTGCGAGCGGTGCCGGTGCGCGGAGACGAACCTGTGCACCGGCGGGTACGCGGAGACCGGGTTCACCGAGCCCGGCGCCTTCGCCGACCATCTGACCGTGCCCGCACGGCTGTTGCACCTCCTGCGCGACGACGCCGACCTGCGGGCCGCGGCGCTCCTGGAACCGGCCGCGGTGGTCGCGGCGGCGGTGCGGGCGGGCGGCCTCCGGCCGGGTGAGCGCGTCGCGGTGGTCGGGGCGGGGACGCTCGGGCTGCTCGCGGTGCAGTTGCTCGCGGCTTCCGGCCCCGGTGAGCTGGTGGTGGTCGATCCGCGCGGGGCGCGGGGTGCGCGGGCCCGGGAGTGCGGGGCGACCTCGGCGCTCTCCCCCGTCGCGGCCGAATCCGTACGCGGTTCGTTCGACCTCGTCGTGGAGACCGCGGGGGCGCCGACCACCGCCGCCTCGTCGTGTCTGCTCGCCCGGCGCGGCGGGCGGGTCGTGCTCACCGGGATGTTCACGGAGGGGGCCGTGGGGATCGACCCCGTGCATCTCTCCCTCAGTCAGCTGGAGGTGCGGTCCGTCTTCGGGGCGTCGTCCGCGGCGTGGGGCGATGCGGTGCGGGCGTTCGGGCTCGGGCTGATCGACCCCGCGGCGCTGATCACGCACGAGTTTCCTCTGGAGCGGTTCGGAGAGGCGGTTTCTCTCGTCGGTGGGGGTGACCCCAAGACCGGGAAGGTGCTTTTGCGTCCTTGA	VSSRAIVVERPGAHRLVTRGTPTPGPGEVLVRVAAAGICGSDREVYDGHRDAAYVRYPVIPGHEWSGTVAAVGEGVDPGLLGRRTVAEGFRACGVCERCRCAETNLCTGGYAETGFTEPGAFADHLTVPARLLHLLRDDADLRAAALLEPAAVVAAAVRAGGLRPGERVAVVGAGTLGLLAVQLLAASGPGELVVVDPRGARGARARECGATSALSPVAAESVRGSFDLVVETAGAPTTAASSCLLARRGGRVVLTGMFTEGAVGIDPVHLSLSQLEVRSVFGASSAAWGDAVRAFGLGLIDPAALITHEFPLERFGEAVSLVGGGDPKTGKVLLRP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	99.41	gnl|BL_ORD_ID|1067|hsp_num:0	1041		
BGC0000704.1|Kanamycin_2 # 1081 # 2106 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.731	BGC0000704.1|Kanamycin_2 	1081	2106	+	Loose	450	28.4906	ANT(4')-IIa	35.29	3002624	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGCCCTGTAAGTCGAACCTCGTTCGGCATTTCGGACACGAAGGACCGTCTGTGATCGACACTTCTTCCGTACGTCCCCGTCGCCCCGGCGAACCCGCCCTCGCCCTCGTCGGGCTCGGCGCGCCCCGCCCCGACCCCGGCGACGCCTCGCCCCACGCCTTCCCCGACGGTGGCACCTGGCGCACCGAGATCCCCTCGGTGGAGGGGCCCGAGGCGCTCGCCGTCGTGCTCAAGGAGAGTGCGCGCCTCGACGTGCCCGTGCACCGGGTCAGCCAGGGCAGCGGCGTCTGGATGCTCACCGACGCCGAGATCACCGAGATGACGGAGTCCTGCGCCGAGCGGGACATCGAGCTCTGTCTGTTCACCGGGCCGCGCGGCACCTGGGACATCGGGGGCTCCACGCGCACCGAATCCGGCGGTGCCGGGCTCCGCGCCCGGGGCCACGACGCGCTCGCGGGGTGCGTCGAAGACGCTCTGCGCGCGGCCGAGTTGGGCGTGCGGTGCCTGCTCGTCGCCGATGAGGGCGTGCTGTGGACCCTGCACCGGCTGCGCGCCGTGGGCGCGCTGCCCGCCGACACCACGTTCAAGCTGTCCGCCCTGTCGGGGCCGGTCAATCCCGCCTCGTACGCGGTGTACGAGCGGCTCGGCGCCGACTCCCTGAACGTGCCGTCCGACCTGACGGCGGACCACCTCACCGAGATCCGCCGGGTCAGCCGAGCCCCCATGGACCTGTACGTCGAGGCGCCCGACGACCTCGGCGGCTACATCCGGATGTACGAGGTCGCCGAGCTGATCAGGCGCGGCGCCCCGCTGTACGTGAAGTTCGGCCTCAGCAAGTCGCCCGGCATCTATCCCTACGGTGCCCAGCTGCGCGAGCACACCCTCGCCACCGCCCGCGAGCGCGTGCGCCGCGGCCGCCTCGTCCTCGATCTGCTCGCCCGGCACGGCGCGGACGGCGGCATGTCGCCGCTCGGCTCGCGGCTCCCCGGCGAGCTGCGCCGATTCCCCACCCCGGAAGGGGACTGA	MPCKSNLVRHFGHEGPSVIDTSSVRPRRPGEPALALVGLGAPRPDPGDASPHAFPDGGTWRTEIPSVEGPEALAVVLKESARLDVPVHRVSQGSGVWMLTDAEITEMTESCAERDIELCLFTGPRGTWDIGGSTRTESGGAGLRARGHDALAGCVEDALRAAELGVRCLLVADEGVLWTLHRLRAVGALPADTTFKLSALSGPVNPASYAVYERLGADSLNVPSDLTADHLTEIRRVSRAPMDLYVEAPDDLGGYIRMYEVAELIRRGAPLYVKFGLSKSPGIYPYGAQLREHTLATARERVRRGRLVLDLLARHGADGGMSPLGSRLPGELRRFPTPEGD	MHLTITYWIDRLREAYPHAVAILLKGSYARGEASAWSDIDFDVLVSDEEVEEYRTWIEPVGERLVHISVAVEWVTGWERDSADPSSWSYGLPTQETTQLLWAADENIRRRLDRPFKVHPAAEPEVEDTVEALGKIRNAMVRGDDLAVYQAAQVVGKLIPTLLVPINPPTYARFAREAIDRILAFPNVPEGFAADWLTCMGLVDRRTHDPQPTRPNEWCAARSRFCRRMRTSSVRISRGCWKQDWYLRISART	135.32	gnl|BL_ORD_ID|1193|hsp_num:0	1266		
BGC0000704.1|Kanamycin_3 # 2111 # 3220 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.667	BGC0000704.1|Kanamycin_3 	2111	3220	+	Loose	650	25.7942	vanF	28.33	3002908	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGCGCATCCGCACGCTCGCCCTCGCCACGACCGCCGCGGCACTCGCCCTGTCGCTCAGCGCCTGCGGCCAGGAGGCCAAGGGCGGCAGCCGCTACCGCCCTGACGACGGCAAGGGCGGCACCATCGGTCTCGCGATGCCCACCAAGGCGTCCGAGCGGTGGATAGCCGACGGCAGGAACATGGCTTCGCAGTTCAAGAAGGCCGGTTACGACACCGATCTCCAGTACGGCGACGACAAGGTGGAGAACCAGGTCGCCCAGCTCGAGAACATGATCACCAAGGGGCACCGGCTCCTGGTGGTCGCCGCGATCGACGGCTCCGCGCTCACCGACGTACTGGCTCGGGCGCACGACGCGGGCATCCCCGTGATCTCGTACGACCGTCTCATCCTGGGCACCGAGAACGTCGACTACTACGCGTCGTTCGACAACGAACGCGTGGGCAGGCTGCAGGGGCGGTACCTCGTCGACAAGCTGGGGCTCGGCAAGCCGGACAGGGACTCCGGGGACACCTACTCCGTCGAGCTGTTCGCGGGCTCCCCCGACGACAACAACACCAAGTACTTCTGGAACGGCGCCATGAAGGTGCTGAAGCCGTACCTGGACAGCGGGCAGCTCGTCGTACGCAGCAAGCAGACGCGGATGAACCAGGCGACCACGCTGCGCTGGGACGGCGGCACCGCGCAGAAGCGCATGGACGACCTGATCAGCAAGAGCTACGGCGAGCGGCGCGTGGACGCCGTCCTCTCGCCGTACGACGGGATCTCCATCGGCGTCATCTCGGCGCTCAAGAGCGCCGGTTACGGGACGAGGAGCGAGCCGCTGCCGGTCATCACCGGACAGGACGCCGAGCTGGCGTCGGTGAAGTCGATCATCCGGGGCGAGCAGACGCAGACCGTCTTCAAGGACACCCGCAAGCTCGCCGCGCAGACGGTGAGGATGGGCGACGCGGTCCTGACCGGCAAGAAGGTCGAGGTCAACAACACCACGGACTACGACAACGGCGAGAAGACCGTGCCGTCCTTCCTCCTGAAACCGGTCAGCGTCGACAAGACGAACACCCAACTCCTGGTCGACGAGGGCTACTTCAGCGCGGGGCAGCTCTCGTGA	MRIRTLALATTAAALALSLSACGQEAKGGSRYRPDDGKGGTIGLAMPTKASERWIADGRNMASQFKKAGYDTDLQYGDDKVENQVAQLENMITKGHRLLVVAAIDGSALTDVLARAHDAGIPVISYDRLILGTENVDYYASFDNERVGRLQGRYLVDKLGLGKPDRDSGDTYSVELFAGSPDDNNTKYFWNGAMKVLKPYLDSGQLVVRSKQTRMNQATTLRWDGGTAQKRMDDLISKSYGERRVDAVLSPYDGISIGVISALKSAGYGTRSEPLPVITGQDAELASVKSIIRGEQTQTVFKDTRKLAAQTVRMGDAVLTGKKVEVNNTTDYDNGEKTVPSFLLKPVSVDKTNTQLLVDEGYFSAGQLS	MNRLKIAILFGGCSEEHDVSVKSAKEIANNIDTEKYEPIYIGITRSGVWKMCEKPCMDWDNENCRSAVLSPDKKMHGLLVMRNKGYQIQRIDAVFSVLHGKSGEDGAIQGLFELSSIPYVGCDVQSSAVCMDKSLTYIVAQNAGFGTPEFLILNHGDIPDSNTLTYPVFVKPARSGSSFGVNKVNNEDELDAAIETARQYDSKVLIEQAVPGLEVGCAVLGNGTDLIVGEVDQISLSHGIFRIHQEDQPEKGSENAVVLVPANLSAEKRIKIQETAKAIYKALGCKGLSRVDMFLQENGRIILNEVNTLPGFTAYSRYPRMMAAAGMTLSGLIDHCITLALKG	107.58	gnl|BL_ORD_ID|1658|hsp_num:0	1759		
BGC0000704.1|Kanamycin_4 # 3217 # 4782 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=8bp;gc_cont=0.688	BGC0000704.1|Kanamycin_4 	3217	4782	+	Loose	1280	78.1814	macB	29.69	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAGCGCACCGATCCTGGAGATGCGCGCCATCACCAAGACGTTCCCCGGCGTCACGGCGCTCTCCGACGTGAACCTGACGGTGCGCCCCGGGGAGATCCACGCGATCTGCGGGGAGAACGGCGCGGGCAAGTCGACGCTGATGAAGGTCCTCAGCGGCGTCCATCCGCACGGGAGTTACGACGGGGAGATCCTCTTCGAGGGCGAGCCGATGGCCTTCAAGGACATCCGGGCCAGCGAGCGCCGGGGCATCGTGATCATCCATCAGGAGCTGGCACTCGTCCCCCACTTGTCGATCGCGGAGAACATCTTCCTCGGCAACGAGCAGGCGCGCGGCGGCTTCGTCGACTGGAACGGCACCCTGCGCAGGGCGGGCGCACTCCTGAAGCGGGTCGGTCTGCGCGAGAAGCCGCAGACGCCGGTCGCCGACATCGGCGTGGGCAAACAGCAGCTCGTGGAGATCGCCAAGGCCCTGTCGAAGGAGGTGCGGCTGCTCATCCTGGACGAGCCGACAGCCGCGCTCAACGACGACGACAGCGCGAAGCTGCTCGGCCTCATCGGGGAACTGCGCGAGCAGGGCATCGCCTGCATCATCATCTCGCACAAGCTGAACGAGATCCGGGCCGTCACCGACGCGGTGACCATCCTGCGCGACGGGCGCACCGTCGAAACCCTGACGGTCCGTGAGACTCCGGACGCCGAGGCCGAGTTGTCGGAGGACCGCATCATCCGCGGCATGGTCGGCCGCGACCTCGACCACCGCTTCCCCGACCGTACGCCCTATGCGGGCGAGGACGCGGGCACGCTCGCGCTGTCCGTCGCGGGATGGACCGTGCGGCACCCGGTCGACCAGCAGCGCACGGTCGTCGACGACGTGTCGCTGACCGTGCGGCGCGGCGAGATCGTCGGCATCGCGGGCCTGATGGGCGCGGGCCGCACCGAACTCGCGATGTCCGTCTTCGGGCGCTCGTACGGCGTCTACGTCGCCGGGGACGTGGCGGTGAACGGCCGCCCGGTGGTGACGCGGACCGTCCCCGCCGCGGTCGACGCGGGCATCGCGTACGTCACTGAGGACCGCAAGCGGTACGGCCTCAACCTCATCGACGACATCAACCGCAACGTCTCCCTGGCCTCGCTGCCCGGCATGCGGCGCCGGGGCGTCGTGGACGAGCACCACGAGCGCTCGGTCGCCGAGCGCTACCGCAAGGCCATGAACATCAAGGCGCCCACCGTCTTCGAGGAGGTGGGCAGGCTCTCCGGCGGCAATCAGCAGAAAGTCGTCCTGAGCAAGTGGATCCACGCCGACCCCGAGGTGCTGATCCTCGACGAGCCGACGCGCGGCATCGACGTGGGCGCCAAGTACGAGATCTACACGGTCATCGACGAGCTCGCCGCGCAGGGCAAGGCCGTCCTGTTCATCTCCTCCGAACTCCCCGAGCTGCTCGGGATGTGCGACCGGATCTACACGATGGCCGAGGGCCGCCTGACCGGTGAGGTCACGCGCGCGGAGGCCACCCAGGAAGTCCTGATGCGCCACATGACCCAGACCAGAAGCCCCAAGAGCTGA	MSAPILEMRAITKTFPGVTALSDVNLTVRPGEIHAICGENGAGKSTLMKVLSGVHPHGSYDGEILFEGEPMAFKDIRASERRGIVIIHQELALVPHLSIAENIFLGNEQARGGFVDWNGTLRRAGALLKRVGLREKPQTPVADIGVGKQQLVEIAKALSKEVRLLILDEPTAALNDDDSAKLLGLIGELREQGIACIIISHKLNEIRAVTDAVTILRDGRTVETLTVRETPDAEAELSEDRIIRGMVGRDLDHRFPDRTPYAGEDAGTLALSVAGWTVRHPVDQQRTVVDDVSLTVRRGEIVGIAGLMGAGRTELAMSVFGRSYGVYVAGDVAVNGRPVVTRTVPAAVDAGIAYVTEDRKRYGLNLIDDINRNVSLASLPGMRRRGVVDEHHERSVAERYRKAMNIKAPTVFEEVGRLSGGNQQKVVLSKWIHADPEVLILDEPTRGIDVGAKYEIYTVIDELAAQGKAVLFISSELPELLGMCDRIYTMAEGRLTGEVTRAEATQEVLMRHMTQTRSPKS	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	80.90	gnl|BL_ORD_ID|459|hsp_num:0	487		
BGC0000704.1|Kanamycin_5 # 4791 # 6032 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.683	BGC0000704.1|Kanamycin_5 	4791	6032	+	Loose	950	27.7202	msrE	29.79	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGACGACCACGACCACTCCCCCGGGCTCCTCCCGGGACGCGTCCGACGCCCCGCCACCCGCGCGGTGGCCGGCGGGCGCGCTGCTGCTGCGAAGCGTGCGCTCCAACACGCGCCAGTACGGCATGCTCATCGCCCTGGCGTTCCTCGTCGTGCTGTTCCAGATCTGGACCGACGGGACGCTGCTGCTCCCGAACAACGTCTCCAACCTGATCCAGCAGAACGGCTACATCCTCATCCTGGCCATCGGCATGATGATCGTCATCATCGCGGGCCACATCGACCTCTCCGTGGGCTCGTTGGTCGCCTTCGTCGGCGCCATGTCGGCGGTCATGATGGTCAAGCACGACATGCCCTGGGTGCTCGCCCTGGTCCTCTCGCTCCTGATCGGCGCGGTCGCGGGGGCCTGGCAGGGCTTCTTCATCGCGTACGTCGGCATCCCCTCGTTCATCGTGACGCTGGCCGGGATGCTGCTCTTCCGCGGACTCACCCAGATCGTCCTTGAGGGCCAGTCGCTCGCGCCGTTCCCCGACGGGTTCCAGAACATCGCCAAGGGCTTCATCCCGGAGATGGGCCCCTACACCCAGTACCACAACCCGACGCTCGTCCTCGGCCTGCTCGCCGTCGCGTTGCTGCTCCTGCGTGAACGGCGCGCTCGCAAGCGCCAGTTGGCGTACGAGCTCGATGTCCTGCCGACCGGTCTGTGGGCGGCCAAGTGCGTGGCGATGACCGCGGCCGTGGTGGCGTTCACCCTCACCCTCGCCAGCTTCCACGGCGTGCCCGTCGTCATGCTCATCATGTGCGGCCTGCTCATCGCGCTGGGCTATGTCATGCGCAACGCCGTCATCGGCCGCCATGTGTACGCCCTCGGCGGCAACAAGGCCGCGGCGAAGCTGTCGGGCGTCAAGGACAAGCGGGTCACCCTCCTGGTCTTCGTGAACATGGGCGTCCTCGCGGCGCTCGCGGGCTGCGTGTACGCGGCGCGCCTGAACGCGGGCACCCCGCAGGCCGGGCTCAACTTCGAACTGGAGGCGATCGCCGCCTCGTTCATCGGCGGCGCGTCGATGAGCGGCGGCGTCGGCACGGTCCTTGGCGCGGTCATCGGCGGCCTCGTCCTCGGCGTCCTGAACAACGGCATGTCCCTGGTCGGCATCGGCACGGACTACCAGCAGGTCATCAAGGGGCTCGTACTGCTCGCCGCGGTCGGCTTCGACGTCTGGAACAAGCGCAAGGCGGGCCGCTAG	MTTTTTPPGSSRDASDAPPPARWPAGALLLRSVRSNTRQYGMLIALAFLVVLFQIWTDGTLLLPNNVSNLIQQNGYILILAIGMMIVIIAGHIDLSVGSLVAFVGAMSAVMMVKHDMPWVLALVLSLLIGAVAGAWQGFFIAYVGIPSFIVTLAGMLLFRGLTQIVLEGQSLAPFPDGFQNIAKGFIPEMGPYTQYHNPTLVLGLLAVALLLLRERRARKRQLAYELDVLPTGLWAAKCVAMTAAVVAFTLTLASFHGVPVVMLIMCGLLIALGYVMRNAVIGRHVYALGGNKAAAKLSGVKDKRVTLLVFVNMGVLAALAGCVYAARLNAGTPQAGLNFELEAIAASFIGGASMSGGVGTVLGAVIGGLVLGVLNNGMSLVGIGTDYQQVIKGLVLLAAVGFDVWNKRKAGR	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	84.11	gnl|BL_ORD_ID|27|hsp_num:0	33		
BGC0000704.1|Kanamycin_6 # 6252 # 7226 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=3bp;gc_cont=0.723	BGC0000704.1|Kanamycin_6 	6252	7226	-	Loose	556	26.9498	erm(32)	37.5	3004592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCGGCGCAGACGCTGCGCGCGGCCGCCCGGATGCGGGTGGTCGAGCTGATCGGCGACAAGGAGCGGACCGCCGCCGAGGTCGCCGCAGAGGCCGGGGCCCGCCCCGAGGGCATGATCCGGCTGCTGCGCGCGCTCGCGGGCATCGGCGTGGTGGCGGAGCGGACGCCGGGCGTCTTCGCGGTGACGCCCACGGGCGCCCTGCTCGACTCGCGACGACCCGGCAACGTCGCGTCCCTGGTGCTCATGATGTCCGACCCGACGATGCTGCGCGGCTGGGAACACCTCGACGAGGTCGTACGGACGGGTGAGCCCGCCTTCGACACGGTGTTCGGCACGGACTTCTTCGGCCACCTCAGGGAGCATCCCGAGGAGTCCGCCCGGTTCAACGAGGCGATGAGTCAGAGCACCGGGGCGGCGGCCGCCACGCTGCCCCGCGCCTTCGACTTCACCAGGTTCGCCACCGTCGCCGACGTCGGCGGCGGCGACGGCACGCTGCTCTCCGCCGTACTGAAGGAGCACACGGGCCTCACGGGCATCATCTACGACACGGCGGAGGGCCTGGCCCAGGCACCCGCGACGCTGGAGCGGCACGGGCTCACCGAGCGGTGCTCGTCGGTGGCCGGTGACTTCTTCCAGTCGGCCCCCAAGGGCGCCGACCTCTACCTCCTGAAGAGCATCCTGCACGACTGGCCGGACGAGCGGGCGGTGACCATCCTGAGCCACTGTCGCGCGGTGCTGCCGCCCGAGGGCCGGGTGCTGATCCTGGAGCACGTCCTGCCCGAGGCCGTCGACCCGGCGGCCCCGGGGTTCGCGTATCTGAGCGATCTGAACATGCTCGTGAACCTGGGCGGCAGGGAACGCACCCGGGCCGATTTCGACGAGCTCTGCGGCAGGGCCGGGCTCTCCATCGTGTCCGTGACGCCGATGGGGGCGCCGAACCCGCTCTCGATGATCGAGGTGGCGGCCGCCTGA	MAAQTLRAAARMRVVELIGDKERTAAEVAAEAGARPEGMIRLLRALAGIGVVAERTPGVFAVTPTGALLDSRRPGNVASLVLMMSDPTMLRGWEHLDEVVRTGEPAFDTVFGTDFFGHLREHPEESARFNEAMSQSTGAAAATLPRAFDFTRFATVADVGGGDGTLLSAVLKEHTGLTGIIYDTAEGLAQAPATLERHGLTERCSSVAGDFFQSAPKGADLYLLKSILHDWPDERAVTILSHCRAVLPPEGRVLILEHVLPEAVDPAAPGFAYLSDLNMLVNLGGRERTRADFDELCGRAGLSIVSVTPMGAPNPLSMIEVAAA	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	115.71	gnl|BL_ORD_ID|2787|hsp_num:0	3294		
BGC0000704.1|Kanamycin_7 # 7552 # 8388 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.729	BGC0000704.1|Kanamycin_7 	7552	8388	+	Loose	2090	25.0238	smeB	28.57	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGACCCGGCGTCCACCGCACTGCAGCAGGAGATCGCCCGGGATCTCCAGGTGTCCGCGAGCTTCGACCCGGCGCGCGAGATCGAGCGCCGCGTCGCCTTCCTCACCGAGCGGCTGACCTCGACGGGGCTGCGCTCGCTGGTGCTCGGCATCAGCGGAGGGGTGGACTCCACGACCGCGGGACGGCTGTGCCAGCTCGCCGTCGAGCGGGCCCGCACCGCCGGGCACGAGGCGACCTTCTACGCCATGCGCCTGCCCTACGGCGTCCAGGCCGACGAGAAGGACGCGCAGCTCGCACTGGGCTTCATCGCCGCCGACCAGGTCCTGACCGTGGACGTGAAGGCCGCGAGCGACGCCGCGCTGGAGGCCGCGCTCACCGGCGGGGTCGTCTTCAGGGACGAGCGCCACCAGGACTTCGTGCAGGGCAACATCAAGGCCCGGCAGCGGATGATCGCCCAGTACGCGGTCGCGGGCGCGCGGGACGGTCTGGTGGTCGGCACCGACCACGCGGCCGAGGCGGTCTCCGGGTTCTTCACCAAGTTCGGCGACGGCGCGGCCGACGTCGTGCCGCTGACCGGTCTGACCAAGCGCCGGGTGCGGGCGGTCGCCGACGCGCTCGGCGCCCCTGCCGAGCTGGTGTGGAAGGTCCCGACGGCGGACCTGGAGACGCTCGACCCCGGCAAGCCGGACGAGGACGCGCTCGGCGTGACGTACGACGAGATCGACGACTTCCTGGAGGGGAAGCCGGTGTCCGACGCGTCGTTCCGGTCGATCGTCGGCCGCTACCGCCTCACGGACCACAAGCGCAGGCTGCCGATCGCGCCGACGGCCTGA	MTDPASTALQQEIARDLQVSASFDPAREIERRVAFLTERLTSTGLRSLVLGISGGVDSTTAGRLCQLAVERARTAGHEATFYAMRLPYGVQADEKDAQLALGFIAADQVLTVDVKAASDAALEAALTGGVVFRDERHQDFVQGNIKARQRMIAQYAVAGARDGLVVGTDHAAEAVSGFFTKFGDGAADVVPLTGLTKRRVRAVADALGAPAELVWKVPTADLETLDPGKPDEDALGVTYDEIDDFLEGKPVSDASFRSIVGRYRLTDHKRRLPIAPTA	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	26.50	gnl|BL_ORD_ID|1854|hsp_num:0	1960		
BGC0000704.1|Kanamycin_8 # 8454 # 8894 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=13bp;gc_cont=0.673	BGC0000704.1|Kanamycin_8 	8454	8894	-	Loose	500	23.483	OXA-96	28.21	3001631	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAGGCCGCTATGACCAGAGACGAGATCGAGGTCAGGGCGTTGTTGGAGAGCCGTGCCGACGCCGCGCAGGCGAAGGACATCGACCGGCTCATGCCGCTTTTCGCGCCGGACGTCGTCTACTTCGACGTCGTGCCGCCGATGCGGTTCGCGGGGCACGGCGAAGTGCGCAAGAACTTCGTGCGGTGGTTCGAGGGCTATGAGGGGCCCATCACGCTGGAGACGCGGGAGCTCACCGTCGCGGTCGGGGACGACGTCGCGTTCGCCCACATGCTGCACCTGGATTCCGGAACCCGTACGAACGGGATGCAGAGCGCGATGCTGGTGCGGTCGACCGTGTGCTGTCGGCGGGTGAGCGGCACGTGGCTGATCACGCACGAGCACATCTCGCTGCCGATCGACCCGGCGACGCTGCAGGCCTGGATGCCGCCCCAGGCGTGA	MEAAMTRDEIEVRALLESRADAAQAKDIDRLMPLFAPDVVYFDVVPPMRFAGHGEVRKNFVRWFEGYEGPITLETRELTVAVGDDVAFAHMLHLDSGTRTNGMQSAMLVRSTVCCRRVSGTWLITHEHISLPIDPATLQAWMPPQA	MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQMGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL	52.14	gnl|BL_ORD_ID|566|hsp_num:0	605		
BGC0000704.1|Kanamycin_9 # 8990 # 9712 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=8bp;gc_cont=0.721	BGC0000704.1|Kanamycin_9 	8990	9712	-	Loose	400	29.6462	Erm(K)	46.15	3004643	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGCGTCACGAGTAAGTACCGGGCCGCCTGGGAGTCGTTCTGGAGCGACGCGCCCGACGAACAGGGCGCCGTGTTCTGGGACGCCGAACCCGCTCTGACCGCGGGACTCCACCTCGCCCTCTTCGAGCCGCACCTGGCCGCCGCGGGGCTGCCCATCATCGATCTGGGCTGTGGCAACGGCACCCAGACGCGGTTCCTCGCCGACCGCTATCCGCGCGTCCTCGGCGTCGACATCTCCGCCGCCGCGCTCGATCACGCCCGGCGGGCGGACCCGGCGGGACAGGCCGACTTCCGGCAGCTCGACATCGCCGAGTGGAGCGTCGCCGAGCAGCTGCACGCGGAACTCGGCGATGTGAACGTCTACATGCGCGGCGTGCTCCACCAGTGCGATCCCGACGACAGGCAGCCGCTGCTCGACAACATCGCGCGCCTGGTGGGGGAGCGCGGCAGAGCCTTCGTCGTCGAACTGTCCGAGGCCGCCAAGCCCGTCCTGCTCGGCCTGGCGCAGAGCCCCACGGGCCCGCCGCCGAAGCTGGCGCCGGTCTTCGCGCACGGCCTCGCACCGGCCGAGGTCGTCGACGAGGCGGTGCGGGAGTACGTCGCGGCCGCGGGCCTCGCGGTCCTTGCCGAGGGGGAACTCCCGCTGACCACCACCGAGTTCAGGCCCGATGGCACGCGGATCGAACTGCCGTCGTGGTGGCAGGTCCTCGGCCTGGACTGA	MSVTSKYRAAWESFWSDAPDEQGAVFWDAEPALTAGLHLALFEPHLAAAGLPIIDLGCGNGTQTRFLADRYPRVLGVDISAAALDHARRADPAGQADFRQLDIAEWSVAEQLHAELGDVNVYMRGVLHQCDPDDRQPLLDNIARLVGERGRAFVVELSEAAKPVLLGLAQSPTGPPPKLAPVFAHGLAPAEVVDEAVREYVAAAGLAVLAEGELPLTTTEFRPDGTRIELPSWWQVLGLD	MTKKKHKYSNKKLSRGEPPNFSGQHLMHNKKLLQEIVDQAKVSKKDTVLELGAGKGALTTFLSERAKRVLAVEYDQTFIQVLNRKMAHAANTTIIHEDIMRIHLPKGEFVVVSNIPYSITTPIMKKLLSNPVSGFQRGVIVMEKGAAKRFTSPFIKNAYVLAWRMWFDLEYVKGISRECFSPPPKVDSAMVFISRKPDPIVPYKDRSAFFGLAEYALREPKAPADSLLRGIFTATQLKHVKRNAGIKHDVSIGALSERQWGVIFETMTQYVRRPLWPRPRKTTL	84.51	gnl|BL_ORD_ID|2179|hsp_num:0	3341		
BGC0000704.1|Kanamycin_10 # 9907 # 12405 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=8bp;gc_cont=0.723	BGC0000704.1|Kanamycin_10 	9907	12405	-	Loose	500	25.7942	mphA	27.85	3000316	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGGAACAAGGCACTCCGGGCAGCGGGCCTGTGGCGCAGCGTGCCATGGCCGGACGCATCCCGTTGGCCGTGGTCGTCGTCGACGGCAGCGGTCTCGTCTCCCACTGGAGCACCGGCGCGCGACGCCTCTTCGGGTACGCCAAGGAGGACGCCGTGGGGCGCCCCGTGGGCGACCTGCTCCCGGTGCACGGCGCGATACCCGACGCCGCCGGGCCCTACGGGGAGTACGACGGACTCGGCCCCGACCTGGAGACCTCCCTCGACGGCCGCATCTCCTACCCGGCGGCAGGGCGCGCCCGCCTCGACGAGCCGGGCAGCGACCCCGCCCGCCGTCTCGACGTGCTGTGGTGGGCGTATCCGCTGGTCGGCCCAGGACCCGAGCGGCTGCTCGTGCTCGCCGCCGACGCCGCCGCGCTGACCGACGCCGGCCGCGCGGAGGACCGGGACGAGCAGGGTGAGCAAGCGGAGCTGGGAGAGCGGGACGACCGGGCTCAGGGGGCCACGTCGTTCAGGCACTGGGGCAGCATCGCCCCCGGGTTCGCCCTGCACACGGACTTCCCCGGTGCGGACCGGCTCGCGGACGGACTGCCCGAGATCCTGCCCAGCATGAGCGTCGGCGAGAGCTCCCGCATCGTCGCGCAGGTGCTCGAACTGGGCTATCCGGTACTCGAGTTCAGCCAGCACGACCGGGTGCCCGTCACCCCCGACTGGGGCGTGGCCCGGCGCGCCGAGCGCAAGGAACGCAGGCAGCGCGCCGCGCGGGCCGCCGCGCACGGCCTGCCCGCCGCGGTCACGGCCGACGACGAGGGCGACGACCTCGAGTACGCAGCCGTGCGCGAGCACCTCGAATTCCTGAACGAGGTCAGCGGGCGCATCGGTTCCTCGCTCGATCTGGCGCAGACGATCGTGGAGGTCAGCAAGGCGGTCGTGCCGCGCTTCACGGACGTCGCGGGCACCTACCTGCGGGAACAGGTCGTCGCGGGCGAGGGGTTCCCCGAGGGGGTGCCGGACGAGACCACGATGTGGCACCGGGTCGCCCTTGAACACACGGACGAACCGGGCCGCTGGGACGACGTGGTGCCGGTCGGCGAGTCCATGCCGTTCCCGGTGCACACCCCGTTCTTCCAGTGCATGACCTCCGGAGACCCGGTGCTCGTGCCGCGCATCACCGAGGAGATGGGCAACGCCATCGCCTCCCAGTTCGAGAAGCGCGACATCCGCCCGCTGATCAACCACCGCTCGATGCTCGTCGTACCGCTCAAGGCGCGCAATGTGGTGCTCGGCTTCATGATCCTGCTCCGCCACCGCGAGCGCCCCGTCTTCAACGACATGGACCGCGTCACCGGCTCCGAACTGGCCGCCCGCGCGGGCCTCGTGCTCGACAACGCCCGCATGTACACCTACCAGGAGAGCGTCGCCGACACCCTCCAGGACAGCATGCTGCCGCACATCGACCCCCGCATGCCCGGCGGCGACATCGCCACCCGCTATCTGCCGGGCACACTGCTCGGCCGGGTCGGCGGCGACTGGTTCGACTCCGTGAAGCTCCCGGGGTCGCGGACCGCGCTCGTCGTCGGCGACGTGATGGGCCACGGCCTGAACTCGGCGGCGATGATGGGCCAGTTGCGCACCGCGGTGCAGACGATGGCCGCCCTCGACCTGCCGCCCGAGCAGCTCCTGCGCAACCTCGACGACCTCGCACAGCGCCTCGGCGAGCACTATCTGGCGACGTGTCTCTACGCGGTCTACGACCCCATCGCGAGCGAGCTGAGCCTCGCCAACGCCGGGCACATCCCGCCCGTCCTGGTGCGCGCGGCGGACGGCCGCAGCGAACTCCTCGACCTGCCGACGGGTGCGCCCATCGGTGTCGGCGGCGTGCCCTTCGAATCCGTACGCATCAGGGTCGCGCCCGGCGACCGGCTGCTGATGTGCACCGACGGTCTCGTCGAGGTCCGTGGCGAGGACATCGGCGTCGGCCTCGCCACGCTCACCGAGTCCGCCGCGCACCCCGCCGCCTCCATGGACGACGCCTGCGACACGATCATCCGGGCGCTCAACACCCGCGGCGGCCGCAAGGACGACGTGGCGCTCCTGATGGCCAGGCTCAACGGCATCGCCGCCGACGACGTCGCGCACTGGCGGTTCGAGACCGGGCCAGGCGAGGTGAGCAGGGCCCGCGAGCTGGTCCGCGCGCAGCTGCGGGAGTGGTCCCTCGGCGCGCTCGCCGACACCGCGGAGCTGCTCGTCAGCGAGCTCGTCACCAATGTCGTACGCCACTCCCGCAGCGAGCGGCTCGAACTGCGCCTGGTCCGTTCCGCCGTGCTGATGTGCGAGGTCGAGGACGACGACCACACGCTGCCGACGCTCCGGAGCGCGGGCGGCGACGACGAGTTCGGGCGTGGCCTGCGGGTCGTGAGCGCGCTCGCCAAGGAGTGGGGCACGAGCCGTACGAACGCGGGGAAGACCGTCTGGTTCGAACTGGCGCTGCCCCGGCGGTAG	MEQGTPGSGPVAQRAMAGRIPLAVVVVDGSGLVSHWSTGARRLFGYAKEDAVGRPVGDLLPVHGAIPDAAGPYGEYDGLGPDLETSLDGRISYPAAGRARLDEPGSDPARRLDVLWWAYPLVGPGPERLLVLAADAAALTDAGRAEDRDEQGEQAELGERDDRAQGATSFRHWGSIAPGFALHTDFPGADRLADGLPEILPSMSVGESSRIVAQVLELGYPVLEFSQHDRVPVTPDWGVARRAERKERRQRAARAAAHGLPAAVTADDEGDDLEYAAVREHLEFLNEVSGRIGSSLDLAQTIVEVSKAVVPRFTDVAGTYLREQVVAGEGFPEGVPDETTMWHRVALEHTDEPGRWDDVVPVGESMPFPVHTPFFQCMTSGDPVLVPRITEEMGNAIASQFEKRDIRPLINHRSMLVVPLKARNVVLGFMILLRHRERPVFNDMDRVTGSELAARAGLVLDNARMYTYQESVADTLQDSMLPHIDPRMPGGDIATRYLPGTLLGRVGGDWFDSVKLPGSRTALVVGDVMGHGLNSAAMMGQLRTAVQTMAALDLPPEQLLRNLDDLAQRLGEHYLATCLYAVYDPIASELSLANAGHIPPVLVRAADGRSELLDLPTGAPIGVGGVPFESVRIRVAPGDRLLMCTDGLVEVRGEDIGVGLATLTESAAHPAASMDDACDTIIRALNTRGGRKDDVALLMARLNGIAADDVAHWRFETGPGEVSRARELVRAQLREWSLGALADTAELLVSELVTNVVRHSRSERLELRLVRSAVLMCEVEDDDHTLPTLRSAGGDDEFGRGLRVVSALAKEWGTSRTNAGKTVWFELALPRR	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	276.41	gnl|BL_ORD_ID|1170|hsp_num:0	1243		
BGC0000704.1|Kanamycin_11 # 12547 # 14982 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=8bp;gc_cont=0.726	BGC0000704.1|Kanamycin_11 	12547	14982	-	Loose	950	261.536	tcr3	37.62	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGGCGGGACGACGCTGGTGAAGGCCGTCGAGCGGGACGGCACGGAGGCCGTCGAGGCGGCCGACGCACCCCCCGAGCGGGGCGCGGCACAGGCCCCGCCGCCCCCCGCTCCGGGGGCCACGGCGCACGGGCTCAGCCCCCGCCGGGTCCGGATGGTCTTCGTCGGGCTGATGCTCGCCCTGCTGCTCGCCGCCCTGGAGCAGATGATCGTCGCCACCGCGCTCCCGAAGATCGTCGGTGAGCTGCACGGCCTGGACAAGATGTCCTGGGCGATCACGGCCTATCTGCTGACCTCGACGGTCGGACTGCCCATCTACGGCAAGCTCGGCGACCTCTTCGGCCGCAAGGGCGTCTTCCAGTTCGCGATCGTCATCTTCGTCATCGGCTCGGCCCTGGCCGGCTGGTCGCGGACCATGGACGAGCTCATCGCGTTCCGCGCCATCCAGGGCGTCGGTGCGGGCGGTCTCATGATCGGCGTACAGGCGATCATCGCCGACATCGTGCCGCCCCGGCAGCGCGGCCGCTACATGGGCCTGATCGGCGCCTCCTTCGGCCTCGCCTCGGTGGCGGGACCGCTGCTCGGCGGCTTCTTCACCGACCACGCCTCCTGGCGCTGGTGCTTCTACTTCAACGTGCCCTTCGGCCTGGTCACGCTCCTCGTCGTCAGCCTGGTCCTGAAGCTGCCCAAGCCCGCGTCGCGGGGCAGACTCGACGTCCTCGGCGCGCTGCTGCTCGCCGCCGCCTCCACCTGCCTGGTGCTGCTCACCAGCTGGGGCGGGACCGAGTACGCCTGGGGCGACCGCGTCATCCTGGGGCTCGGCGCGGGAGCCGTCGCATCGGCGCTGCTCTTCCTCGTCGCCGAGCACTTCGCGGCAGAACCGATCATCCCGCTGCGCCTGTTCCGTGATCCGGTCTTCAACATCACCGGTCTTGTGGGCATGGTCGTCGGAATCGCCCTCTTCGGAGCGGCCAGTTATCTGCCGACCTTCCTGCAGATGGTCGACGGCGCCAGCGCCACCGAGTCCGGCCTCCTGATGCTGCCGATGATGGGCGGCATCGTCGGCGCCTCGGTCATCTCCGGCCAACTGATCAGCCACACCGGCCGCTACAAGATCTATCCGGTGCTCGGCGGCGCCCTCTCCGTAGTGGGCATGTGGCTGCTCTCGCGCCTCGAAGTCGACACGCCCCGGCTGCAGTACAGCATCTGGATGGCCGTGCTCGGCGCCGGTATCGGCATGGTCATGCCGGTCCTGGTCCTCGCCGTGCAGAACGCGGTGCGGCCCGCGGACCTCGGCACCGCCACCAGCGCCAACAACTACTTCCGGCAGATCGGCGGCAGCGTCGGGGCCGCCATCTTCGGCACGCTCTTCGCCAACCGGCTCGCCGACGCGCTGGCCGACCGCATCCCGGCGGACGCGGGGGCGGCCCTGCCCGACGCCGAGTCCATCACCCCGCAGCTCGTCCACGCGCTGCCCCCGGCGCTGCGCGACGGCTACATCGAGGCCTACGCCGACGCGATGCCGCGGATCTTCCTCTACCTGGTGCCGGTGCTCGTCCTCGGCATGCTGATCGCCTTCTTCCTCAAGGAGACCCCCCTGTTGTCCAGCGCAGCTTCCCAGAACGCACCCGCCGCCGAGCCCGCGCCCGTCCCCCAGGCCCGTACGTCGACGTACACCGCGGGGGTCCCGGTGTGCGGCACCGTGCAGCACCCCGACGGCACCGTGGTGCCCCGCGCGGCCCTGACCCTCATCGACGTCGCCGGGCAGCAGATCGGCCGCGGCGCCAGCGGCGAGGACGGCCGGTACGCCCTGTCCACGCCGGGATCGGGCTCGTTCGTGCTCATCGCGGCCGCGGGCGGTCACCAGCCGCAGGCCGTCACCGTCACCGTCGGCGAGCGCCCCGTCGACCTCGACGTGGTCCTGGGCGGCGCGGGCCGCCTCGCGGGGACCGTCGTCACCGCCGACGGGACGCCCGTCAGGGACGCCGCGGTCACCCTCACCGACGTCCGCGGCGAGGTCGTCGCCACCACCCGCAGCGGCCGCGAGGGCAGCTACGTGATCACGGAGTTGGTGGCGGGCGAGTACACGCTCGCGGCCAGCGCCCCCGCCTTCCGGCCCGCCGCGCTGCCCGTCTCCGTGCAGGCCTCCAGGGAGACCCGGCAGGACGTGGAACTCGCGGGCGGCGCCGTGCTGCGGGGTACCGTGCGGGCCAGCGGCGGGCGGCCCGTGGAGGACGCGCGCGTGACGCTGCTCGACGCCGCGGGCAACGTCGTCGACACCCTGACCACGGGAGCGGACGGCACGTTCCGCTTCATCGACCTGTCGTCCGGCGAGTACACCGTCATCGCGGCGGGCTACCCGCCGGTCGCCACGGTGTTGCAGGTCGCGGGCGGCGGCCGCACCGAGCGTGACCTCCAGCTGGGGCACGAGGACTGA	MGGTTLVKAVERDGTEAVEAADAPPERGAAQAPPPPAPGATAHGLSPRRVRMVFVGLMLALLLAALEQMIVATALPKIVGELHGLDKMSWAITAYLLTSTVGLPIYGKLGDLFGRKGVFQFAIVIFVIGSALAGWSRTMDELIAFRAIQGVGAGGLMIGVQAIIADIVPPRQRGRYMGLIGASFGLASVAGPLLGGFFTDHASWRWCFYFNVPFGLVTLLVVSLVLKLPKPASRGRLDVLGALLLAAASTCLVLLTSWGGTEYAWGDRVILGLGAGAVASALLFLVAEHFAAEPIIPLRLFRDPVFNITGLVGMVVGIALFGAASYLPTFLQMVDGASATESGLLMLPMMGGIVGASVISGQLISHTGRYKIYPVLGGALSVVGMWLLSRLEVDTPRLQYSIWMAVLGAGIGMVMPVLVLAVQNAVRPADLGTATSANNYFRQIGGSVGAAIFGTLFANRLADALADRIPADAGAALPDAESITPQLVHALPPALRDGYIEAYADAMPRIFLYLVPVLVLGMLIAFFLKETPLLSSAASQNAPAAEPAPVPQARTSTYTAGVPVCGTVQHPDGTVVPRAALTLIDVAGQQIGRGASGEDGRYALSTPGSGSFVLIAAAGGHQPQAVTVTVGERPVDLDVVLGGAGRLAGTVVTADGTPVRDAAVTLTDVRGEVVATTRSGREGSYVITELVAGEYTLAASAPAFRPAALPVSVQASRETRQDVELAGGAVLRGTVRASGGRPVEDARVTLLDAAGNVVDTLTTGADGTFRFIDLSSGEYTVIAAGYPPVATVLQVAGGGRTERDLQLGHED	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	158.40	gnl|BL_ORD_ID|607|hsp_num:0	652		
BGC0000704.1|Kanamycin_12 # 15186 # 15629 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.676	BGC0000704.1|Kanamycin_12 	15186	15629	-	Loose	1650	26.9498	Brucella suis mprF	28.99	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGCGCAGGTCGAGGCGACCACGGAGCGGATCATCGCGGCACAGCCTGACGATGTCTTCGACGCACTGGCCGACTACAACGGCACGCGCGAGAAGATCCTTTCCGACCACTTCAGCGAGTACGAGGTGCGCGAGGGCGGCGACGGCGAGGGCACCCTCGTCCACTGGAAGCTGCAGGCCACCAGCAAGCGCATCAGGGACTGCCTGCTCGAGGTCGGCGAGCCGAACGACGGCGAACTGGTCGAGAAGGACCGCAACTCCTCGATGGTCACCACCTGGACCGTGACCCCGGCGGGCGAGGGCAAGTCCCGCGTAGTCGTCTCCACCGTGTGGAACGGCGCGGGCGGCATCGGCGGCTTCTTCGAGAAGACGTTCGCGCCGAAGGGCCTCGGGCGGATCTACGACGCCGTGCTCGGCAAGCTCGCCGCCGAGGTCGAGAAGTAG	MAQVEATTERIIAAQPDDVFDALADYNGTREKILSDHFSEYEVREGGDGEGTLVHWKLQATSKRIRDCLLEVGEPNDGELVEKDRNSSMVTTWTVTPAGEGKSRVVVSTVWNGAGGIGGFFEKTFAPKGLGRIYDAVLGKLAAEVEK	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	16.70	gnl|BL_ORD_ID|2109|hsp_num:0	2281		
BGC0000704.1|Kanamycin_13 # 15751 # 17013 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=15bp;gc_cont=0.728	BGC0000704.1|Kanamycin_13 	15751	17013	-	Loose	700	26.9498	pexA	25.88	3004666	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCATGATCGGATCATGCTCGTAGAGTTCCTGTCCGTCGCCGCCCTTGTCGTGGTCCTGGTCTGCGCCGTCGTCCGGCCGTTCCGCTGGCCGGAGGCGGCCTTCGCCGTACCGGCCGCCGGGGTCGTGGTCCTGAGCGGCGCGATCCCGCTCGACGACGTGCGCGAGGAGGCCGCGCGGCTCGGCCCGGTGATCGGCTTCCTCGCGGGCGTCCTCGTACTGGCGAAACTCTGCGCCGACGAGGGGCTCTTCCACGCCTGCGGGACCTGGATGGCACGCTGGGCCGCGCGACGCCCGCGACGGCTCCTGACCGCCGTCTTCGGGCTCGCCTCCGTGATCACCGCGGCGCTGAGCCTGGACGCCACCGTGGTCCTGCTGACCCCGGTGGTCTTCGCCACGGCGGCGCGCATGGGCGCCCCGCCCAAACCACACGTCTATGCGAGTGCCCATCTGTCCAACACCGCCTCGCTCCTGCTGCCCGTGTCGAACCTGACGAACCTGCTCGCGTTCACCGCGACGGGGCTGAGCTTCACGCGCTTCGCGCTGCTCATGACGCTCCCCTGGCTGGTCGCCATCGCCGTCGAATACGCCGTGTTCCAGCGGTTCTTCGCCGCCGAACTCGACGCACCCGTCGACGGCGGCGATACGGCGGAGCCGCCCGAGATGCCGCTGTTCGCCCTGGTGACCGTCGTCGCCACGCTCGCCGGGTTCGCCGTCGCCTCGGCCGTCGGCATCGATCCGGCCTGGGCCGCGGCGGCCGGGGCGCTCGTCCTCGGCGTACGGGCCCTGCTGCGCGGTCGTACGACCCCGGTGGCGATCCTGCGCTCGGCCTCCCTGCCGTTCCTGGCCTTCGTCCTGGCGCTCGGCGTCGTCGTCAGGGCCGTCGTCGACAACGGACTCGGCGACGCGCTCGGCCACGTCCTGCCGGACGGCGCCTCGCTGCCCGCGCTGCTCGGCACCGCGGCCGTCGCCGGGCTGCTCGCCAACCTGATCAACAACCTGCCCGCGGTCCTCGCCCTGGTCCCGCTGGCCGCGCCGTCCGGGCCAGGCGCCGTCCTCGCCGTGCTGATCGGCGTGAACATCGGACCCAACCTCACCTACGCGGGCTCCCTCGCCACGCTCCTGTGGCGGCGCATCGCACATCAGCACGAACACGACGTCGACCTCAGGGAGTTCACCCGCCTCGGTCTCCTCACCACGCCCGCGGCCCTCGTCCTGTCGACCCTCGCGCTCTGGGTGTCCCTGCGGCTGCTGCCGGTGTGA	MHDRIMLVEFLSVAALVVVLVCAVVRPFRWPEAAFAVPAAGVVVLSGAIPLDDVREEAARLGPVIGFLAGVLVLAKLCADEGLFHACGTWMARWAARRPRRLLTAVFGLASVITAALSLDATVVLLTPVVFATAARMGAPPKPHVYASAHLSNTASLLLPVSNLTNLLAFTATGLSFTRFALLMTLPWLVAIAVEYAVFQRFFAAELDAPVDGGDTAEPPEMPLFALVTVVATLAGFAVASAVGIDPAWAAAAGALVLGVRALLRGRTTPVAILRSASLPFLAFVLALGVVVRAVVDNGLGDALGHVLPDGASLPALLGTAAVAGLLANLINNLPAVLALVPLAAPSGPGAVLAVLIGVNIGPNLTYAGSLATLLWRRIAHQHEHDVDLREFTRLGLLTTPAALVLSTLALWVSLRLLPV	MKKFVLFCERNGIALIPIVLILLGCGLWPEMELLVPSLPDMQRAFNIQDAQIQQLLTANFVGFLIGVLFAGPLCDSAGRRTVMMIGTIGYLVSSVLCPFCNDFVLLMIARFFQGLFMTGPVIAGGVLLMEATEGVKQIFWMSIGNAAITFCMAAGPIVGSWINTGFGYVGNLWSILILGLIGCLPALFLVPESLPVEKRAAFHPKLLFKGYFALLKDFRFMCLAIPMCALAAAYWIYVGVSALYMVNQLGIAQEMFGRYQGPIVGCFSIISLGSSKLLQRFGLMKCLRAGIVSMFTGMLLLLGMSILSLDHAVATTVFMMFFVGGMAPICSMLFPYALGHLPVDLKGNAQAMVQAIRLFFASIGTSLVGVFYKSAFLPVALIMFAILLFSCYFLWKGRRYLKEGLGADHILSVGH	101.20	gnl|BL_ORD_ID|2284|hsp_num:0	3366		
BGC0000704.1|Kanamycin_14 # 17064 # 17258 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.610	BGC0000704.1|Kanamycin_14 	17064	17258	-	Loose	500	20.7866	vph	70.0	3003061	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	viomycin phosphotransferase	ATGTCCGTGATGGACAAGCTCAAGCAGATGCTCAAGGGGCATGAGGACCAGGCGGGGAAGGGTATCGACAAGGCAGGCGACTTCGTCGACGACAAGACCCAGGGCAAATACAGCTCTCAGGTCGACACGGCCCAGGACAAGCTCAAGGAACAACTGGGCGGAGACCAGGGCCAGGACCAGCCGCCCCAGTCGTGA	MSVMDKLKQMLKGHEDQAGKGIDKAGDFVDDKTQGKYSSQVDTAQDKLKEQLGGDQGQDQPPQS	MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR	22.30	gnl|BL_ORD_ID|1152|hsp_num:0	1223		
BGC0000704.1|Kanamycin_15 # 17351 # 17824 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=12bp;gc_cont=0.660	BGC0000704.1|Kanamycin_15	17351	17824	+	Strict	275	316.235	AAC(6')-Ib-SK	99.36	3002593	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGAACTGAACGGTGAGAAAGTGCTGCTGCGGCCCGTGCTCGACAGCGATGTGAAGAAGCTCGACAAGATCGTCAGAGAACCCGAGGTGGCCGCTTGGTGGTCGACCCCCGATGACTACGAGGAGATGCTCGCCATCACCCTCGACGGCGAGGTCATCGGGGCAGTGCAGTACGAGGAGGAGGAAGACCCCGAGTTCCGCCACGCGGGCATCGACATCTTCCTCACGGCGAGTCGGCACGGCCTCGGCCTCGGCACGGACACCGTCCGCACCGTGGCACGTTGGCTGATCGACGAGCGGGGACACCACCGGATCACCATCGACCCGGCGGTGGCGAACGCGGGCGCGATCCGCAGCTACAGCAAGGTGGGCTTCAAGCCGGTCGGCGTCATGCGGTCATACGCCCGTGACCACACGAGCGGCGTGTGGCAGGACGCCCTGCTGATGGACCTGCTGGCCGAAGAGCTGGTCTGA	MELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYEEMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERGHHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV	MRAHRSCCIRRRGLGHNAGVELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYEEMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERGHHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV	89.20	gnl|BL_ORD_ID|967|hsp_num:0	1024		
BGC0000704.1|Kanamycin_16 # 17890 # 19056 # -1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.714	BGC0000704.1|Kanamycin_16 	17890	19056	-	Loose	500	26.9498	chrB	31.67	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	TTGGCCCATACGGCGACCGTGGCCCAGTACGTCAGTGCCGCCGCCATGGGGGCGGTGGTCCTGTTGCGCGCCCCCGCCGCCGCCCGGAGTCCGGCCCAGCGCGGCCTGTGGCTGGCCGTCGCGACGGCCGCGGTCGCCATGGCGCTGCAACTGCCGGTCGTCATCAGGGCCGCCCTCGACCTCACGGGCAGCGTGCACGAGGTGGGTCTGGCCAGGAACCTCTTCGGGGTGTTGTCGGCGGGGTGCGTGCTGTACTTCGTCACGGCGGCGGCCCAGCACCGCTGGTGGCGCTGGGGACTCGTCACGTCGGTGGCGCTGGTCGTCCTCGCCCTGGTCCTGCTCGACCAGGTGCGGGAACAGCACGACAACCCGGGCGGTCCTTCGTCGCTCAGCGCGTACTGGGCCATCCTGATGGGCAGTCACATCGTGGCCAACACGGTCTGCGTCCACGTGTGTCTGTGGCAGGGCTGCCGGGCCTCGGCCCCTTCTCTCCGCCTCAGCCTGTGGATCTTCGGGGCGGGCACGGCTCTGGTCGGGATCTATTGGTGCGTGGCCCTTGGACGGCTGATCATCGGTGAGCCGCCCCTGCGGAACCTGTCCCTGCTGATGAGCCTGCACGGCTTCCTGCGGGCGGCCGCCCTGCTGGTGCCCCTGTGGGGCTCGATGCGCTCCCAGCCGTCACAGATCAGGACCCTGTGGGTGCTGTGGCCCCTGTGGCGAACCCTGGTGCAGGCGGTGCCGCACGTGGCGCTCCACCGGCGGCGCTCCCGGATCGTCGAGGTGGTGTGGCCGCGCGCGCCGCGCCGACTGGCCGTCTACCGCAGGATGATCGAGATACGGGACGCGATCCTCTCCCTGCACGGCTACGTCCATCCCGCGCTGCCGGGAGCCGTGAAGAGCCGGGTGGAACAGCTGGGTCTGCACGGGCGCTCCGCCGACGCGATGACGCTGGCCTGTCTCCTGCACGTGGCCCTGCGGGCCAGGCGGACGGGGGCGGCCAAGGACTTCGACGCCTCCCTCTCCCACGGCTGGGACAGCGTGAACATCTCTGGTGAAGAATCGTTTCTTCTGGAACTCGCACGCGCCTTCCGCACGCCGGTCGCCCGCTCGCTCGCCGGTCAGCTCGGCGGCCGGACGGGCGGCCTCACCGAGGTCGGCGACGGGTGA	MAHTATVAQYVSAAAMGAVVLLRAPAAARSPAQRGLWLAVATAAVAMALQLPVVIRAALDLTGSVHEVGLARNLFGVLSAGCVLYFVTAAAQHRWWRWGLVTSVALVVLALVLLDQVREQHDNPGGPSSLSAYWAILMGSHIVANTVCVHVCLWQGCRASAPSLRLSLWIFGAGTALVGIYWCVALGRLIIGEPPLRNLSLLMSLHGFLRAAALLVPLWGSMRSQPSQIRTLWVLWPLWRTLVQAVPHVALHRRRSRIVEVVWPRAPRRLAVYRRMIEIRDAILSLHGYVHPALPGAVKSRVEQLGLHGRSADAMTLACLLHVALRARRTGAAKDFDASLSHGWDSVNISGEESFLLELARAFRTPVARSLAGQLGGRTGGLTEVGDG	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	138.57	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0000704.1|Kanamycin_17 # 19058 # 19645 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.662	BGC0000704.1|Kanamycin_17 	19058	19645	-	Loose	225	24.2534	FosB	38.1	3000172	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	ATGCATGTCCGCAGGACCGCCTACTACCGATGCCCCGCTCAAGGCCTACGGAAAGAGCATATGTCTTATATATATGTGAAACTCCGACAGCGTTGCCAGGCGATCGTGGACGGACTCAGCCTGCCGCACCCCTTCACCGTCGAATCCTTCTGTACGCGCCTCGCGGCCCAGCGTCAGCGGCCCCTTCATCTGCACGCCTTGCCGCGGCAGGCGGCCCAGGCGGGCGCGTGCGGATTGTGGCTGGCCACGGACATCGACGACCACATCTTCTTCGAGCAGCGCACGGCCCGCGTGCATCAGGACCACATCATCCTGCACGAGATCGGCCACATGCTCTTCGGTCATCAATCGCTCGAACTGGGCGAGGGCTGGGGCGATGCGCCCCAGCTCTTCGGGGACCTCAGCCCGCAGCTGATCCAACGGCTGCTCGCCCGCACCGACTACACCACCCGGCGGGAGCAGGAGGCCGAGATGCTGGCCAGCCTGATCCGCACCAGGGGCGAACAGCCCGCCGGTGAACGGCACGCGGACGACGTGCTTCACTACCTCGGCGAGGCACTCGGCGTGGGAGCGACCCGTGGGGGCTGA	MHVRRTAYYRCPAQGLRKEHMSYIYVKLRQRCQAIVDGLSLPHPFTVESFCTRLAAQRQRPLHLHALPRQAAQAGACGLWLATDIDDHIFFEQRTARVHQDHIILHEIGHMLFGHQSLELGEGWGDAPQLFGDLSPQLIQRLLARTDYTTRREQEAEMLASLIRTRGEQPAGERHADDVLHYLGEALGVGATRGG	MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEVHQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY	141.30	gnl|BL_ORD_ID|1474|hsp_num:0	1567		
BGC0000704.1|Kanamycin_18 # 19703 # 20185 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=9bp;gc_cont=0.615	BGC0000704.1|Kanamycin_18 	19703	20185	-	Loose	700	24.2534	mdtG	35.71	3001329	protein homolog model	n/a	n/a	fosfomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGGGACGGCGCGGCGGAGCGTTCCGAAAGCGGCAGGCTGCTGCTGGATAAACTCGACCAGCGCATCAAAGATCTCATTTGCGCCATCTATCCGGACAAGGGCACCCGGCCCGGTTATGCGCGGCTCGCGCAGGACATAAGAGAAACCACCGGCGGGACCATCTCGGGAACGTACCTATGGGAATTGGCCACCGGCAAGAAACGAAACGTCACGCTGGAACAACTCGGTGTCCTGGCAGACTATTTCGGGGTACCGCCTGAGTACTTCCTCAATGACGAGGTGTCCGAACGGGTAAACGCTCAACTCGCACTGGCAACGGCCCTCAGGGACAACCGGATTCGCAATCTCGCGCTTCGGGCGGAAGGCCTTTCGCCCTCCACCTTGGACGCGTTGCTGGTCATGGTGAACGAGGCCCGGAAGATCCAGAACCTGTCCCCACCGGCTGACGAAGACGGGCGCGGTCCCCAGCACACGGAGTGA	MRDGAAERSESGRLLLDKLDQRIKDLICAIYPDKGTRPGYARLAQDIRETTGGTISGTYLWELATGKKRNVTLEQLGVLADYFGVPPEYFLNDEVSERVNAQLALATALRDNRIRNLALRAEGLSPSTLDALLVMVNEARKIQNLSPPADEDGRGPQHTE	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	39.22	gnl|BL_ORD_ID|564|hsp_num:0	603		
BGC0000704.1|Kanamycin_19 # 20685 # 21722 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000704.1|Kanamycin_19 	20685	21722	+	Loose	500	26.5646	sul4	40.91	3004361	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	GTGCGCGAGAGTGATATCCAGGCCGCCTCGCTTCCCCCGGAAAGCAAGTCCGAGCTATTCCAGCGGAGTTCGGTGCGCGTTCCGCTCGACCTGCTCCTGCCCGCGGTGTCCCCCCGCATCGCAGGCGTGGACGAACGGCACGTCCGGTCGCTCGCCGGGATCGAGGCCCCGCTGCCGCCCATCGTGGTGCACCGCGCCACGCTGCGGGTGATCGACGGGACGCACCGGCTGCTCGCCGCCCGCGCCCGGGGGGAGACGGACGTGGAGGTGCAGTTCTTCGACGGCGGTGAGGCCGATGCCTTCGTCCTCGCCGTCGCCCTCAACAACGCCCAGGGGCTGGCGCTCTCCCCGGCCGATCGCAGTACGGCGGCGGCGCGCATCATCGCCTCCCATCCGCACTGGTCGGACCGCCGCATCGCCCGCGTCACCGGCCTGGCCGCCAGCACAGTGGGCGGTGTCCGCAGGCGTTCGACCGCTCGAACCGCACAGCCGAACGCGCGCCTCGGCATGGACGGCCGCATCCGCCCGCAGGACATCGCCCAACGGCGCAGGCTGGCCGGGCAGTTCCTCGCCGAGCAGCCGGGGGCCTCCCTGCGGACCGTGGCGAAGGCCGCCGGGATCTCCTTGAGCACGGCCCACGACGTACGGACGCGACTGCGGGCGGGCGACGATCCGCTGCCCCCCGCGCTGTCCAGGCCGACGCGGCCGCCCGCCGCGCCGGACAGCGCGGCCGACGCCGCGGACCGGCCCGCCAAGCCGTCCTCCGCACGCTCCCCGCGAAGCCCCGGGCGCGCCCCCGTCGCCGCCGATCTCCTGGACCGGCTGCGCAAGGACCCCTCGCTGAGGTTCACGGAGGACGGCCGGATCCTTCTTCACTGGCTCGGCGCCGCCGTGCTCCGCGAACACGGCGCCGCACGGTTCGCCCGCTGCGTACCGCCGCACAGGACCGCCGCCATGGCGGCCCTCGCCCGCAGCTGTGCGGAGGGCTGGCTCCGTCTCGCCGAATCCCTCGACCAGCGCGGCAGGTCCGACGCGTGA	MRESDIQAASLPPESKSELFQRSSVRVPLDLLLPAVSPRIAGVDERHVRSLAGIEAPLPPIVVHRATLRVIDGTHRLLAARARGETDVEVQFFDGGEADAFVLAVALNNAQGLALSPADRSTAAARIIASHPHWSDRRIARVTGLAASTVGGVRRRSTARTAQPNARLGMDGRIRPQDIAQRRRLAGQFLAEQPGASLRTVAKAAGISLSTAHDVRTRLRAGDDPLPPALSRPTRPPAAPDSAADAADRPAKPSSARSPRSPGRAPVAADLLDRLRKDPSLRFTEDGRILLHWLGAAVLREHGAARFARCVPPHRTAAMAALARSCAEGWLRLAESLDQRGRSDA	MSTTLTSFKWGERTYIMGILNVTPDSFSGDGVMVEEDVIAKAVAQAKQFVADGADIIDIGGESTRPGSSPISAEEELARVLPVVQAVRQAVDVVISIDSYRASVAEAALAAGASWLNDVWGLRMDPDMAGLAAQAGCPIVLMHNRSKPKNIAQEKKLGGRFIGVKYDDLITDVKRELQESIDIALKAGVKESQIILDPGIGFGKTVEQSLQLLDQINQFKTMGFPILIGPSRKSFIGYTLDLPPDQRIEGTAATVAIGIDRGADVVRVHDVKAIVRVARMTDAIVRR	120.21	gnl|BL_ORD_ID|2548|hsp_num:0	2875		
BGC0000704.1|Kanamycin_20 # 21817 # 22848 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.712	BGC0000704.1|Kanamycin_20 	21817	22848	+	Loose	600	29.6462	vanHM	24.18	3002947	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGAAGGCACTCGTGTTCCACAGCCCCGAGAAGGCGACCTTCGAACAGCGCGACGTCCCCACTCCCCGGCCGGGCGAAGCCCTCGTCCACATCGCGTACAACTCCATCTGCGGCAGCGACCTCTCGCTCTACCGCGGTGTCTGGCACGGCTTCGGCTACCCCGTCGTGCCCGGACACGAGTGGAGCGGCACCGTGGTCGAGATCAACGGCGCCAACGGACACGACCAGTCGCTGGTCGGCAAGAACGTGGTGGGCGATCTGACCTGCGCGTGCGGGAACTGCGCGGCCTGCGGGCGCGGGACCCCGGTGCTCTGCGAGAACCTCCAGGAACTCGGCTTCACCAAGGACGGCGCCTGCGCCGAGTACATGACCATCCCGGTCGACAACCTCCGCCCGCTGCCGGACGCGCTGTCGCTGCGTAGCGCCTGCCAGGTCGAACCGCTCGCGGTGGCGCTCAACGCGGTCAGCATCGCGGGCGTCGCTCCCGGTGACCGGGTCGCCGTCATGGGGGCCGGGGGCATCGGCCTCATGCTGATGCAGGTCGCGAGGCATCTCGGCGGTGAGGTGACGGTCGTGTCCGAACCGGTCGCCGAACGGCGCGCGGTCGCCGGGCAGTTGGGCGCCACCGAGCTGTGCTCCGCCGAGCCGGGGCAGCTGGCCGAACTCGTCGCCCGGCGCCCCGAGCTCACGCCCGACGTGGTCCTGGAGGCATCCGGCTATCCGGCTGCGCTCCAGGAGGCCATCGAGGTGGTCAGGCCGGGCGGCCGCATCGGCCTGATCGGCTACCGGGTGGAGGAGACGGGACCGATGTCCCCGCAGCACATCGCGGTCAAGGCGCTGACCCTGCGCGGCTCGCTGGGCCCCGGCGGCCGCTTCGACGACGCCGTCGAACTGCTCGCGAAGGGCGACGACATCGCGGTCGAGCCGCTGCTCAGCCACGAGTTCGGCCTCGCCGACTACGCCACCGCGCTCGACCTGGCGCTGTCCCGCACGAACGGCAACGTGCGCTCCTTCTTCAACCTGCGCGACTAG	MKALVFHSPEKATFEQRDVPTPRPGEALVHIAYNSICGSDLSLYRGVWHGFGYPVVPGHEWSGTVVEINGANGHDQSLVGKNVVGDLTCACGNCAACGRGTPVLCENLQELGFTKDGACAEYMTIPVDNLRPLPDALSLRSACQVEPLAVALNAVSIAGVAPGDRVAVMGAGGIGLMLMQVARHLGGEVTVVSEPVAERRAVAGQLGATELCSAEPGQLAELVARRPELTPDVVLEASGYPAALQEAIEVVRPGGRIGLIGYRVEETGPMSPQHIAVKALTLRGSLGPGGRFDDAVELLAKGDDIAVEPLLSHEFGLADYATALDLALSRTNGNVRSFFNLRD	MVLVMKDIGITIYGSEQDEADVFQEISSRFGVTPTIVSSPISETNVMLAPKNKCISVGHKSEIHKSILIALKESGVKYISTRSIGYNHIDMKAAEKMGIAVENVTYSPDSVADYTLMLILMAIRHTKSTLCSMEKHDFRLNSVRGKVLRDLTVGVLGTGHIGKAVIERLQGFGGHVLAYGNNKEATANYVSFNELLQKSDILTIHVPLSDDTYHMIGHEQIKAMKQGAFLINTARGGLIDTEVLVKALEDGKLGGAALDVLEGEEGLFYFDCTQKPINNQFLLKLQRMPNVTITPHTAYYSEKTLRDTVEKTVKNCLEFERRETHE	105.21	gnl|BL_ORD_ID|1624|hsp_num:0	1724		
BGC0000704.1|Kanamycin_21 # 23013 # 24188 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=4bp;gc_cont=0.692	BGC0000704.1|Kanamycin_21 	23013	24188	+	Loose	800	39.6614	tetA(P)	21.31	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAGCTCGTTCCGCTCTTCCCGCTCTATCCCCTGCTCTTCTCCGACCACGGATTGTCGGGATCGGCGATCTCCTCGCTGCTCGTCCTGTGGTCGATGACCACGTTCGTCCTGGAGATCCCCTCGGGCGCGCTCGGCGACCTGCTGTCCCGCAGGCTGCTGCTCGCGTTCAGCGTGCTGCTGCGGGCGGGCGGGTTCAGCCTCTGGTTCATCGCACCCGGCTACTGGTCCTTCGCCGTCGGATTCCTGTGCTGGGGAGTCTGTGACGCCCTGACCTCCGGCACCCTGGAGTCCCTCGTCTACGACGAACTCCAGGACCGCGGCGAAGGACATGCCTACGGCCCCGTCATGGGCACCGGGCGGGCCATCTCGCTGCTCGCCACGCTCACCGCACTGCTCCTGGCCGGGCCGCTCTTCGTCCTCGGCGGGTACGGTCTGGTCGGCGCGGTCAGCGTCGGTGCGGGCGTGGCGGCCACCATCACCGCACTGACCTTCCCCAATCCACCGCGCCACGAGATCGAATCCGAACGCGGCGGCTTCCACCGCTATCTCGCCACCTTCAAAGCCGGGTTCGGGGAGGTCCGCAGGGAACGGGCCGTCATGCGGCTGGTGTTGATCGCCGCGATCCTGCAGAGCATGACGGCCATCGACGAGTACTTTCCGCTGCTCGCCCACGAGAACGGCGCGGCCAAGAGCCTCATCCCGGTCCTGGTGGCGATCCCCGTGCTGTGCGCCTCGGTGGGCAGCTGGATCGCGGGCCGCTCCACCGGCGTCTCGCGCAGGACCGCGTTCCTCACCGTGGCGGCGACCGGGCCGCTGCTGCTCCTCGGCGCCCAGAGCCACCACCAGTGGGGGATGCTCTCGATCGCCGTGGCCTTCGGCATCATCCAGTGGGGCATCGTGGTGTCCGGGCTCTGGCTCCAGGACGCCATCGTCGGATCGGCCCGCGCGACCATCACCTCCGTCGCGGGATTCGGCGCCGAGGTCTCCTCGGTCGGCTGGTACCTGGCCGCGGCCACCGCCCTCACGGTCACCGACGTCTCCGGCCTCACGTCGTGGTTCAGCCTCCCCTGCCTCCTGATCGCGGGCCTCACCTGGTTCTGGTTCCCGGAGCGACCGGCATCCGAGCCGACCGAACCGACCGAACCGCAGCCCACCACCTACTCGAAGAGGTAA	MELVPLFPLYPLLFSDHGLSGSAISSLLVLWSMTTFVLEIPSGALGDLLSRRLLLAFSVLLRAGGFSLWFIAPGYWSFAVGFLCWGVCDALTSGTLESLVYDELQDRGEGHAYGPVMGTGRAISLLATLTALLLAGPLFVLGGYGLVGAVSVGAGVAATITALTFPNPPRHEIESERGGFHRYLATFKAGFGEVRRERAVMRLVLIAAILQSMTAIDEYFPLLAHENGAAKSLIPVLVAIPVLCASVGSWIAGRSTGVSRRTAFLTVAATGPLLLLGAQSHHQWGMLSIAVAFGIIQWGIVVSGLWLQDAIVGSARATITSVAGFGAEVSSVGWYLAAATALTVTDVSGLTSWFSLPCLLIAGLTWFWFPERPASEPTEPTEPQPTTYSKR	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	93.10	gnl|BL_ORD_ID|477|hsp_num:0	508		
BGC0000704.1|Kanamycin_22 # 24194 # 25372 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000704.1|Kanamycin_22 	24194	25372	+	Loose	400	24.6386	catB2	38.24	3002675	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GTGTCCACGCACCCCGTCCTGGACTGGAGCCGATCCGCCGAACACCTGCGCCGCTCCCACGGCGTCACCACCGACCCCCGCCCCGACGAGGACGGCCACTACCCCTGCGTACTGACCCGGGGCAGCGGCACTCGCGTGTACGACCTGGACGGCAACGCCTACCTCGATCTCACCGGATCCTTCGGCTCGGTGCTCATCGGGCACGCGGAACCGGCCGTCGTACGGGCGGTGACCGACGTCCTGAGCGAAGGCAATCTCTTCTACACCGGCGCGAGCCCGCGCCGACTGGCCCTCGCGGAGCGGCTCCTTGACTGGTTCCCCTGGTCCGAGCAGGCCATCTTCTACCGCACGGGGTCCTGCGCGGTGTCCGCGGCGGCCCGGCTCGCCCAGCACGCGACCGGCCGCAACCGGGTGCTGAGTTCCGGCTACCACGGCTGGCACGACTGGCACCTGGAGGCGGTGCCCGAGGCCAAGCCCAAGACCTTCGAGTCGTACGCCACCGAGTTCCACAACGACCTGGCGCTCTACCGCTCCTGGCTCGACCGGCACGGCGAGGAGATCGCGGCGGTCGTGGTGACGCCCGAGCCGCACCGCTTCGACCACGCCTACTACCAGGAGCTGCGCGAGGTGGCCAAGGAGCACGGCTGCCTGTTCGTCGTGGACGAGGTCAAGACCGGCTTCCGGGCCGGGGCGGGCGGGTTCAGCGCCCTGGCCGGGATCGAGCCGGACGCCGTGACCGTCTCCAAGGGCATGGCCAACGGACACAGCATCTCCGCCGTGGTGGGCCAGCGACAGCTCACCCAGGAGCTGAGCGAGGCGCACGTCTGGTCCACCTACCAGAACGAACAGGTGGGGTTCGCCGCCGCGTTGGCGTCCCTGGACTTCCTGGAGCGGCACGACGTGGCGGCCGTGACGCGCCGCACGGGTGAGGCGGTCCGGCAGGGCGTGCTCCAGCTCTTCGCCGAACACGGCCTGCCCGTCGGGGCGCCGGGCTGGGGACCGATGTTCGAGCTGGACTTCGACGCCGCCGACGAGGGTCTCGCCGAGCGGCTCGAAGCGGCGCTGCTGCGCCACGGGATCTTCTGCGACACGGGCGACGACTTCAACATGATGTTCCATACCGCGGAGCACACCGACGAGCTCCTCGAGCGGTTCGCCGCCGCGCTCGGCGACCTCTGA	MSTHPVLDWSRSAEHLRRSHGVTTDPRPDEDGHYPCVLTRGSGTRVYDLDGNAYLDLTGSFGSVLIGHAEPAVVRAVTDVLSEGNLFYTGASPRRLALAERLLDWFPWSEQAIFYRTGSCAVSAAARLAQHATGRNRVLSSGYHGWHDWHLEAVPEAKPKTFESYATEFHNDLALYRSWLDRHGEEIAAVVVTPEPHRFDHAYYQELREVAKEHGCLFVVDEVKTGFRAGAGGFSALAGIEPDAVTVSKGMANGHSISAVVGQRQLTQELSEAHVWSTYQNEQVGFAAALASLDFLERHDVAAVTRRTGEAVRQGVLQLFAEHGLPVGAPGWGPMFELDFDAADEGLAERLEAALLRHGIFCDTGDDFNMMFHTAEHTDELLERFAAALGDL	MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIGSFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIGSEAMIMPGIKIGHGAVIGSRALVTKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWDWPLEQIKEAMPFLCSSGIASLYRRWQGTSA	186.67	gnl|BL_ORD_ID|670|hsp_num:0	712		
BGC0000704.1|Kanamycin_23 # 25380 # 26906 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000704.1|Kanamycin_23 	25380	26906	+	Loose	450	27.7202	SLB-1	31.71	3003556	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	SHW beta-lactamase	GTGCGCATCATCTCCGTACAGGAGGCGGCCACCCGCACCTTCGACGTCTGCGTGGTGGGCAGCGGCGCCTCCGGTGCCATCACCGCCGCGGTGCTCGCCGAACGGGGCCTGTCCGTGCTCATCCTCGAACAGGGCACCGCGATCCCGCCGGGCACCGACCACGACGACGTCGAGGACCCCGACACCTGGGCGTACGCACGCGACGGGGAAGGCTGGAGCAAGGAGGGCTATCCCTGGAGCGCCATGGCGTTCGGCGGCGGCACGGTGTTCTACGGCGGCATCTCCTTCCGCTACGAACAGCGCGACCTCGACCCGCCGCCCGCGCTCCTCGGCGACGCCGACTACGCGCACTGGCGGCTGCGGCTCGACGAACTGGAGCCGCACTACGACTGGGTGGAGGACCGGCTCGGCGTGAGCGGCCCGTCCCACGGCCGGGTGGGCGACTACGCCTTCCCCCACTACGCGCGGGGCTCGCTGCCGCACACCCCGATGGGCGGCGCGCTGGCCCGGGGCGCCGACGCCCTGGGGCTGACCCCGCTGTCCACCCCGATGGCGATCAGCGGGGCCAGGGACCGGCACGGCCCCGGCTGCGCCGAGCTGACGCCGTGCACCGGCTTCACCTGCCCGGTCAACGCCAAGGCCGATGTGATCAGCCGCATCCTGGCGCGCGCCGAGGGGGACGTGTCCGTCGCCCTGGACACCAGAGCGGTGCGGTTCGTGGCCTCGGCACCGGGGCGGGCGAAACGTCTCGAAGTGCTCGGCGGCAGTCCCCGCAGCCGCCGCTCGGTCCATGCCGACCGCTTCGTCCTCGCGGCCAACGCCATCCAGTCCGCCGCGCTCCTGCTGCGTTCGGCGGACCGGCGCGAGCCGGACGGCATGGGGAACTCCAGCGGTCAGGTGGGCCGCCACCTGGCCATGAAGAACAGCGTCTACGTCCGCGGCAGGACCCAGGAGCGGATCGTCGCCCACCAGCCGCTGCGCCATCGCTACTCCAGCGTCTGCGTCCTGGACCACCTGCGCGGTGCGGAGTTCCCCGGGCAGCTGGGCGGGATCATCTACGAGGCCAACCCGTGGGAGGACCCCGAGGCCGACCGTCCTGGCGCCGGTTCGCTGCTCCAGCTGGAGTGCCTCCTCGGCGACCGCCCGCAGGCCCGCAACATGGTGCGGCTCGCCAGGAGCCGGGACCGGGACGGGCTCCAGCGCATCGTCATGGACTACCGCCAGCACCCCTTGGACGGCGAACGCCTGGACGTGCTCCAGGGGAAGGCGAAGGATGTACTGCACGCGGCCGGGGCCGAGCGCACCGAGTCCGTCGACAGCGATTTCGCGACCGGCAGCACGCATCTGCACGGCACGCTGCGCGCCGGTGACGACCCCGCGACCTCGGTGACCGACCGGACGGGCCGGCTGCACGACTACGACAACGTGTGGTCGGCGGACGGCGCGACGTTCCCCTTCGCCGGGAACTTCAATCCCACCCTCACCATCCAGGCCAATGCCCGGCGGATCGCGGTCGGCATCTCCTGA	MRIISVQEAATRTFDVCVVGSGASGAITAAVLAERGLSVLILEQGTAIPPGTDHDDVEDPDTWAYARDGEGWSKEGYPWSAMAFGGGTVFYGGISFRYEQRDLDPPPALLGDADYAHWRLRLDELEPHYDWVEDRLGVSGPSHGRVGDYAFPHYARGSLPHTPMGGALARGADALGLTPLSTPMAISGARDRHGPGCAELTPCTGFTCPVNAKADVISRILARAEGDVSVALDTRAVRFVASAPGRAKRLEVLGGSPRSRRSVHADRFVLAANAIQSAALLLRSADRREPDGMGNSSGQVGRHLAMKNSVYVRGRTQERIVAHQPLRHRYSSVCVLDHLRGAEFPGQLGGIIYEANPWEDPEADRPGAGSLLQLECLLGDRPQARNMVRLARSRDRDGLQRIVMDYRQHPLDGERLDVLQGKAKDVLHAAGAERTESVDSDFATGSTHLHGTLRAGDDPATSVTDRTGRLHDYDNVWSADGATFPFAGNFNPTLTIQANARRIAVGIS	MLSLPSYSHEVEPTSTTIQSVTSSLEGQLSISKLADGVYLHHSYKNVSNFGLVEANGLVVIKDKQAFIIDTPWTDNDTQKLVDWITQQGFIPVASISTHSHQDRAGGIGYLNRQGITTTVSETTQQILTENDKTTAKSTFTGMQYIMKTDLVEVYDLGAGHTKDNLVVWLPTQQILFGGCLIKSLNSSTLGYTGEADLQQWPLTIAKVQAQFPQVKIVVPGHGQVGDKALLEHTIELLIPKNETVNSSS	204.02	gnl|BL_ORD_ID|390|hsp_num:0	419		
BGC0000704.1|Kanamycin_25 # 28350 # 29522 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.707	BGC0000704.1|Kanamycin_25 	28350	29522	+	Loose	480	25.7942	adeR	35.0	3000553	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGGTCACCACCATCACGATGGATGACGTCCAGTATCCCTACCGATTAGGCACGGACTGCCTCGACGGCATCGTCACGCGCCTCGGCGAACTCGGCGCCAGCCGCTACCTGATCGTCAGCGACCCCAGGGTCGCCGAGCTGTACGGGCAGGGGCTGCGCGAACGGCTCGCGGAGCAGGCGGGACCCGCCGAGCTGATCACCCATGCCTCGGGAGAACAGAACAAGGGCCTGCCCGCACTGCACGACCTGGCCGAGGAGGCGCTGCGGCGCGGCGCCGACCGGCAGAGCATCGTCGTAGCACTCGGCGGCGGTGTCACCGGGAACATCGCGGGGCTGCTGGCCGCGCTGCTCTTCCGCGGCATCCGTCTGGTGCACGTGCCCACCACCGTGGTGGCCATGCTGGATTCGGTGCTCTCGCTCAAGCAGGCCGTGAACGCGGGAGTCGGCAAGAACCTGGTCGGCACCTTCTACCAGCCCGTCGAAGTGCTCGCCGACACCGCGATGCTGCGCACCCTGCCGGTCCGCGAGGTCAGGTCGGGGATGTGCGAGGTGGTGAAGAACTCGCTCGCCATCCGCCCCAGCATGATCGACCAGCTGTCGGCCGGGCTGCGCCCCGACGGCCGCTATCCCGACGACACGATGCACTGGATCATCTACGAGAGCCTGGCCGCCAAGGCCCAGGTCACGGCGTACGACAAGTACGAGCGCGGCGAGGGACTCATCCTGGAGTACGGGCACACCGTCGGGCACGCCGTGGAGCACTCCTCGCAGGGAGCCGTGCCGCACGGCGCCGCCGTCGCGCTCGGCATGATCGCCGCCGCCCAGGTCTCCCACCGGGCGGGCTGGGCCTCGGCCGAACTCGTCGACCTGCACCGGGAGCTCGTCGCCAAGACCGGGGTCGCGCGGCGCATCCCGTCCGACATACCGCTCTCCGCCGTCAGGCACCGCCTCTCCTTCGACAACAAGCGGGGCTACCTCCCGGCCTCCGCCGACACCTATCCGATGGTGCTGCTCGAATCCCCCGGCAAGGTGCTGCGCAGCGAGGGCACCGTCCTGACGGCGGCGCCACGGGACCTGGTCGACGCGGTGGTCGACGAACTCGCGGAACCCCCACGGCCCGCGGCCGCGAGGACCGACGACGCCGCCACCGTCCTCGGCGGTGCCGGGTGA	MQVTTITMDDVQYPYRLGTDCLDGIVTRLGELGASRYLIVSDPRVAELYGQGLRERLAEQAGPAELITHASGEQNKGLPALHDLAEEALRRGADRQSIVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAGVGKNLVGTFYQPVEVLADTAMLRTLPVREVRSGMCEVVKNSLAIRPSMIDQLSAGLRPDGRYPDDTMHWIIYESLAAKAQVTAYDKYERGEGLILEYGHTVGHAVEHSSQGAVPHGAAVALGMIAAAQVSHRAGWASAELVDLHRELVAKTGVARRIPSDIPLSAVRHRLSFDNKRGYLPASADTYPMVLLESPGKVLRSEGTVLTAAPRDLVDAVVDELAEPPRPAAARTDDAATVLGGAG	MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA	157.89	gnl|BL_ORD_ID|424|hsp_num:0	456		
BGC0000704.1|Kanamycin_27 # 29644 # 30753 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=11bp;gc_cont=0.738	BGC0000704.1|Kanamycin_27 	29644	30753	+	Loose	225	28.4906	Erm(41)	48.15	3000603	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCGCGTCGGCGTCGTCGGTGCGGGGTTCATGGGCGGGGTGCACGCCGAGGTGGTGGCGGCTCATCCCGGCGCCCGGCTCGAAGCGGTGCACGACCTCGACCCCGCCGCCGCCAGGGACCTGGCCGAGCGGTTCCGCGCCGAGCGGGCCGAGCCCTCCTGGGCGGACCTGCTCGCCGACCCCGCGATCGACCTGCTCATCATCACCACGCCCAACGGGCTGCACCACCGGCAGGCGGCCGAGGCGCTGCGGGCGGGCAAGCACGTACTGGTGGAGAAGCCGCTCGGTGTCACGCCGGAGCAGGTGGCCGAGCTCGTCGAACTCGCCGGACGGCACGACCGGGTCCTTGCCCACGGAAGCAACTTCGTGCACAGCCCGAAGTTCGTCCGGGCCCGTCAACTGGTCGCGGACACCGAGGCGTTCGGACGGCCGCACCTGGTCCGGGTCGTCTTCCGCAACTCGGGCCCCGAGGCCGCCTGGGCCGCGTCCAAGGACCTCGCGGGCGGCGGAGCCCTCCTGGACCTGGGCTGTCACGCGGTGGAGCTGTGCCGGTGGCTGCTCGACGGCGCCGACGTCGAGTCGGTCAGCGCCCGACTGCAGCGGGTGCGGCCGCCCCACGACGCCGAAGCGGACCGCGCGTCCGGCACCGCGGGAACCGCGCGGGTCGCGCTGGAGGACCAGGCGCTGCTGGTCATGGAGTTCGCCGACGGCGCGGTCGGGCAGTGCGACGTCTCCTGGGTCACCCAGGGCGGTGAGCAGGTCACCGCGGAGATCATCGGCACCAAGGGCAGGGTCGAGGTCGACCTGTGGACCGGCATGGGGCTGCGCGCCTACTCGGACAAGGGCTATCAGGACGTCTGGGATCCCGAGCAGGGCTGGGTGCATCCGGAATGGGAGTGGATCCGGGCGAGCGGCTACTACCACCAGGACGGCACCGTGATCGAGGCGGTGGGCCAGGGCATCCCCCTCACCCACGGCCCCGCGGAAGCGCTCGCCTCGGCCCGTGTCCTGGCCACCGGTTACCGCAGTCACGCGGAGGGGCGGGTACTGCGGCTGTCCGGCGCGCCGGTCGGCCCTGGCGCGTCGACGACGGCGGCGGGCTCGGAATGA	MRVGVVGAGFMGGVHAEVVAAHPGARLEAVHDLDPAAARDLAERFRAERAEPSWADLLADPAIDLLIITTPNGLHHRQAAEALRAGKHVLVEKPLGVTPEQVAELVELAGRHDRVLAHGSNFVHSPKFVRARQLVADTEAFGRPHLVRVVFRNSGPEAAWAASKDLAGGGALLDLGCHAVELCRWLLDGADVESVSARLQRVRPPHDAEADRASGTAGTARVALEDQALLVMEFADGAVGQCDVSWVTQGGEQVTAEIIGTKGRVEVDLWTGMGLRAYSDKGYQDVWDPEQGWVHPEWEWIRASGYYHQDGTVIEAVGQGIPLTHGPAEALASARVLATGYRSHAEGRVLRLSGAPVGPGASTTAAGSE	MDLGAGHGALTAHLVAAGARVLAVELHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRLLAADLVLQRGAVHKHAKRAPVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR	267.39	gnl|BL_ORD_ID|1899|hsp_num:0	2013		
BGC0000704.1|Kanamycin_28 # 30750 # 30905 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.763	BGC0000704.1|Kanamycin_28 	30750	30905	+	Loose	700	21.9422	cmx	50.0	3002703	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGCCACCGAGCTCGGGGCGACCGCCGACACCGCCGGGCTCCGGAAGACCGCCGACGCCACCGGGCTCGGGATGACCGCCCGGGGCCGCGGCCGACCCGCCGCGGTGCCTCGTCCGTACCTCGTCCGCACCTCACCGATGGAGGGACCATGA	MTATELGATADTAGLRKTADATGLGMTARGRGRPAAVPRPYLVRTSPMEGP	MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN	13.04	gnl|BL_ORD_ID|1283|hsp_num:0	1366		
BGC0000704.1|Kanamycin_29 # 30902 # 32161 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.701	BGC0000704.1|Kanamycin_29 	30902	32161	+	Loose	700	43.8986	LpsB	20.86	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGACCGAGCCTGCCAAGGGTGTGCTCGCGCTGACTCCGTTCTTTCTGTACTCGGAGTACCAGGACCACTGGGATCCCAAGTTCGACCCCATGGGCGGCATGCACCTGCTGGTGCGGGCCCTGGTCGAGGAGATGGCGGGCCGCGGCGTCCCGCACCGGGTCCTGACGATGTCACCGCCCAAGGTGCCCAAGGACATCAGGATCGGGCAGCGGATCAAGGTGCACGCCCGGCGGCTGCCCGTGCTGCCCATCCCCTCCGACCTGGAGGGGTACTTCGGACTCGTCGGCGCCTGGGCCAAGGGCAGCCTGTTGTGGGTGCTGCGCAACCGCAAGCGGCTGCGCCGGGAGATCGGGGCGCGGGTGCACGCGCACTGCGACGGCTCGGGCGCCGCGGCCTTCTACCCGTATCTGATGTCCCGGATCCTCGGCGTGCCGCTGGTGGTCCAGATCCACTCCAGCCGCTATCTGAGCCAGCACCCCACCACGCTCTTCGAGCGGGTGACCGACCCGATCGCCAAGTGGGCGGAGCGGCACGCCGTCCGCAAGGCCGCCGCGGTCCTGATGCTCACCGACCGGGCCCGCGACGAGATGCGGCGCAAGGCCCAGCTGCCCGCGGAGCGCGTGCACCGGCTCGCGTACCTGGCCAGCGACCAGTTCAAGGACGCCGACACCGAGGCGAGGCGGGCGGAACTGCGGGAGCGCTACGGCCTCGACGACCGCCCGATCGTGCTCTACGTGGGGCGGATCGCCGCCGAGAAGGGCGTGGAGTACTACATCGAGGCCGCGGCCGAACTGACCCGCAGGGGCCGGGACTGCCAGTTCGTCATCGCCGGGGACGGTCCCGCCCGGCCGGACCTCGAAAAGCTGATCGGCGCCCGCGGGCTGCGCGACCGGGTGACCATCACGGGCTTCATGTCCCACGAGTTCATCCCATCCATGATCTCCCTGGGCGAACTCGTGGTGCTGCCGTCCCGGTACGAGGAGCTGGGCATCGTCATCCTGGAGTGCATGACCATGCGCAGGCCGCTGGTCGCGCACGACGTGAACGGCGTCAACAAGCTCATCGAGGACGGCACCACCGGAATCGTCGTACCCCCGTTCAGGACCCCGGAGATGGCCGACGCCGTCGAGCGGCTCCTCGACGATCCGGAGCTGCGCGAGCGGATGGCGGAGAACGCCGCCCCGCTGCCCGCCGCCAAGTACTCGCTCTCCGCGGCGGGCGACCAACTGGCGGGCATCTACCGGGAGATCGGGCTGTGA	MTEPAKGVLALTPFFLYSEYQDHWDPKFDPMGGMHLLVRALVEEMAGRGVPHRVLTMSPPKVPKDIRIGQRIKVHARRLPVLPIPSDLEGYFGLVGAWAKGSLLWVLRNRKRLRREIGARVHAHCDGSGAAAFYPYLMSRILGVPLVVQIHSSRYLSQHPTTLFERVTDPIAKWAERHAVRKAAAVLMLTDRARDEMRRKAQLPAERVHRLAYLASDQFKDADTEARRAELRERYGLDDRPIVLYVGRIAAEKGVEYYIEAAAELTRRGRDCQFVIAGDGPARPDLEKLIGARGLRDRVTITGFMSHEFIPSMISLGELVVLPSRYEELGIVILECMTMRRPLVAHDVNGVNKLIEDGTTGIVVPPFRTPEMADAVERLLDDPELRERMAENAAPLPAAKYSLSAAGDQLAGIYREIGL	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	114.48	gnl|BL_ORD_ID|2840|hsp_num:0	3793		
BGC0000704.1|Kanamycin_30 # 32158 # 32907 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=GGAGA;rbs_spacer=7bp;gc_cont=0.737	BGC0000704.1|Kanamycin_30 	32158	32907	+	Loose	500	26.1794	PNGM-1	34.67	3004571	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	PNGM beta-lactamase	GTGAGGGTCCTCCTCGTCTCCCCCCACCCCGACGACATCGCGCTGTCCTTCGGCGGCTGGGTCGCGGCCCACGCCCGCGGGCTCGCGGCCAAGGGCTGGCGGTTCGACCTGCTGACCGTCTTCGGCACGACCCTGTACGCGCCCCACAGCCCGCGCGCCGTCACCAAGGAGGCCATCAGCACGCTCCGGGAGCGCGAGGACCGCGACTACGCGCGCCGTCACGGGCTGCGGCTGACCTCTCTCCGGCAGGAGGACTGCTCCTGCCTGGGCATGGACGACGAGGAGGAGCTCATCGCCCCCGAGGCGACCGATCCTCGCCGGGCCGCCGTGCGGCAGCTGATCGCGGCGGCGCTCGCCGGGGCCGACCTGGTCGTCGCGCCGCTGGCTGTCGGCGGCCACGTGGATCACCGCATCGTCCGCACCGCGGTGCGGCAGTCGCTCGGCGCCACCCCCTGCCTCTGGTACGAGGACCTGCCGTACGCGTTGGAGAGCCCCGTCGAGGTGCCCTCCGACCACCGGCCCTGGCTGGTCGACATCAGGGGGCACGAGGCGGCCAAGCGCGCCGATCTCGCGCTGTACCGCTCGCAGATGACCGCCGCCGACACCTCCGAGGTCCTCTCGTACCGGCCGGACGGCGCGTCCGTCCCGTGCGAGCGGCTCTGGAGTTCGGCGGGCTTCCCCCAGGACCTGGCCGAGCGGATGGCACTGGCCACGCTGGCCGCCGTGACACCCGACAAGGAGTCGCTATGA	MRVLLVSPHPDDIALSFGGWVAAHARGLAAKGWRFDLLTVFGTTLYAPHSPRAVTKEAISTLREREDRDYARRHGLRLTSLRQEDCSCLGMDDEEELIAPEATDPRRAAVRQLIAAALAGADLVVAPLAVGGHVDHRIVRTAVRQSLGATPCLWYEDLPYALESPVEVPSDHRPWLVDIRGHEAAKRADLALYRSQMTAADTSEVLSYRPDGASVPCERLWSSAGFPQDLAERMALATLAAVTPDKESL	MAGGKVTSSTGIAPKRYVYYPGSEELGPDEIRVIACGTGMPTARRAQAAAAWVVELGNGDKFIVDIGSGSMANIQSLMIPANYLTKIFLTHLHTDHWGDLVSMWAGGWTAGRTDPLEVWGPSGSREDMGTKYAVEHMLKAYNWDYMTRAVTINPRPGDINVHEFDYRALNEVVYQENGVTFRSWPCIHAGDGPVSFALEWNGYKVVFGGDTAPNIWYPEYAKGADLAIHECWMTSDQMMTKYNQPAQLALRINLDFHTSAQSFGQIMNMVQPRHAVAYHFFNDDDTRYDIYTGVRENYAGPLSMATDMMVWNITRDAVTERMAVSPDHAWDVAGPSEDLAPDRNRASEYTQYILDGRLNVDEANAHWKQEFMGRTGLTTEDLGVGS	64.51	gnl|BL_ORD_ID|2771|hsp_num:0	3272		
BGC0000704.1|Kanamycin_31 # 32904 # 34163 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.692	BGC0000704.1|Kanamycin_31 	32904	34163	+	Loose	1900	26.1794	TriC	29.09	3003681	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAAGAAGCTGGCGCTGTTCGGCGGAACTCCCGTACGGAACGAGGAGTTCTACGACGGCCCGCACATCGGGCCGCACGATCTCGACCGCCTCAAATCCGTCCTCGACTCGGGGAACTTCGGCGGCATCCCCTTCCCCAACACCCACCACACCGCCTTCGCCGACCTGTTCACCGGCAAGCTCGGCGCCCCGTACGGCCTGATGGTCTCCAACGGCACCATCAGTCTCTCCATCGCGCTGCGCGCCCTGGGCGTGCGTGCCGGGGACGAGGTGATCACCACCGGCTACACCTGGATGGGCACGGCCGCGGCGATCGTGCACATCAACGCCGTCCCCGTCCTGGTGGACATCGACCCCACGACCTGGTGCATCGACCCGGCGGCGGTGGAGGCGGCGATCACCCCGCGCACCAAGGTGATCGTCCCGGTCCATCTGGGCAATCAGATCGCCGACCTCGACGCGCTGCGGGCGATCGCCGACAAGCACGGACTCGCGATCCTGGAGGACACCGCGCACGGGCACTTCGCCGAGTGGCGGGGGCAGTGCGTGGGCACCCACGGGGACGCGGGCAGCTTCAGCTTCGAGAGCAGCAAGATCATGACTGCCGGTGAGGGCGGCTTCCTGGTGGCCAGGGACGAGGACGTGTACCAGCGGATGATGTCGCTGGCCAACTGCGGCCGCAAGGAGCCGGGTTACGACGGTTTCGCGGGCCGCACCCTGGGCTGGAACGCCCGCGCGAGCGAACTGCAGGCCGCCTTCATGATCGGGCAGGTCGAGCAGCACGACGCGCTGCACGCCAAGCGGGCGGCGAGCGCGGCGAAGCTCACCGCGGGGCTCGCCGAGATCGGCGGCTTCACTCCCGTGGGGAACGACGACCCGAGGATCACCCGGCGCCAGTACTACGAGGTCATCTACCGCTTCGACCCCGCCGCCTGGGAGGGGCTGCACCGGGACGAGGTCCTCTCGGCGATCCTTGCCGAGGGCATCGAGCTGGAGGGCGACGCCTTCTACCCGCCCGTACACAAGAGCGAACTGTTCGCGGTGGACGCCGTCCACTGGCCCATGATCGCCGAGAGGTACGGCGATCGGATCGGCCCGGACAGCGTCGACCTGCCCGTCGCCGACCGCGCCGCCGCCGACGAGTCCGTGTGGGTGCACCACGCGCTGCTCACCGGCGACGACAAGGACCTCGGCGACATCCTCGAAGCCGTCGCCAAGGTCCGCGACAACCTGCGAGAACTGCACGACGCGAGCTGA	MSKKLALFGGTPVRNEEFYDGPHIGPHDLDRLKSVLDSGNFGGIPFPNTHHTAFADLFTGKLGAPYGLMVSNGTISLSIALRALGVRAGDEVITTGYTWMGTAAAIVHINAVPVLVDIDPTTWCIDPAAVEAAITPRTKVIVPVHLGNQIADLDALRAIADKHGLAILEDTAHGHFAEWRGQCVGTHGDAGSFSFESSKIMTAGEGGFLVARDEDVYQRMMSLANCGRKEPGYDGFAGRTLGWNARASELQAAFMIGQVEQHDALHAKRAASAAKLTAGLAEIGGFTPVGNDDPRITRRQYYEVIYRFDPAAWEGLHRDEVLSAILAEGIELEGDAFYPPVHKSELFAVDAVHWPMIAERYGDRIGPDSVDLPVADRAAADESVWVHHALLTGDDKDLGDILEAVAKVRDNLRELHDAS	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	41.28	gnl|BL_ORD_ID|2049|hsp_num:0	2194		
BGC0000704.1|Kanamycin_32 # 34322 # 35179 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.698	BGC0000704.1|Kanamycin_32 	34322	35179	+	Loose	750	26.1794	adeA	23.44	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCCTTGCCGCTCCGCCCGGCGAACTGACCCTCGCCCTCACACCGGACGACAAGACCCTCGATCCCGCCTCGCTCGACCGCGCGCTCGCCATACTCGCCGAGCACGGCATCCTGGTGCTGACCGGGATGCTCAGGACCCGGCTCACCGATCAGCTGCGCACGGCGATGCTCGACGACCTGCCCGAGGTGCTGCGGCAGCAGGACGTGCCCACGAACTTCGTGCCAGGACACGTCCAACAGGACCCGCCGGTACGGGAGTCGTTGCTCTTCCCCGACGTGCTGCTCAACCCGGTGGTCTACCAGATCACCCATGCCGTGCTCGGCGCGGACGCCCGCAACGCCGTCTACAGCGGCAACATGAACCTGCCGGGCAGCCACGAGCAGCCGGTCCACCTGGACGAGCCGCACCTGTGGCCGGGCATCAGCCACCCCCCGTACTGCCTCTGCGTCGACGTCCCCCTGATCGACTTCACGCTGGAGAACGGCAGCACCGAGTACTGGCCCGGCTCCCACGTCCTCAACCCCGACGAGTGCTACGACGAGCGGGGCTGTGTGCTGCCCGCCGAGCTGGAGCGGCGCCGGGCCGTCGCGCCGCCGGTCCGCTTCCCCATCCCCGTCGGCTCGGTCGTCATCCGCGACGGCAGGCTGTGGCACCGCGGCGTACCCAATCTGAGCGCGGCCCCCCGGCCCCTGCTGGCGATGACCCACTACACAGAGTGGTTCGACATGCCGCCGATCCAGCTGCCCGACACCGTCAAGTCCTGGGTCGACGGCTCCGATCGGCACACCCACGCGCACTTCGTGGCGGGCGACGTGGATCACCTGACGGGTGATCATCCCTTCGCCGTCCGCTGA	MALAAPPGELTLALTPDDKTLDPASLDRALAILAEHGILVLTGMLRTRLTDQLRTAMLDDLPEVLRQQDVPTNFVPGHVQQDPPVRESLLFPDVLLNPVVYQITHAVLGADARNAVYSGNMNLPGSHEQPVHLDEPHLWPGISHPPYCLCVDVPLIDFTLENGSTEYWPGSHVLNPDECYDERGCVLPAELERRRAVAPPVRFPIPVGSVVIRDGRLWHRGVPNLSAAPRPLLAMTHYTEWFDMPPIQLPDTVKSWVDGSDRHTHAHFVAGDVDHLTGDHPFAVR	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	71.97	gnl|BL_ORD_ID|1239|hsp_num:0	1313		
BGC0000704.1|Kanamycin_33 # 35205 # 36263 # 1 # ID=1_33;partial=00;start_type=GTG;rbs_motif=GGCGG;rbs_spacer=13bp;gc_cont=0.736	BGC0000704.1|Kanamycin_33 	35205	36263	+	Loose	1200	28.8758	arnA	21.55	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGAGCAGTCAACTCGCTCTGCGGGGGCCCGAGTTATCGGCCAATCTTTGCAAACCTGAGGAGGACACTTTGCGGGTTCTTGTCACCGGAGGCTCCGGCAACGTCGGTGTGGGTGTCGTCAGGGCACTCAACGCCGCCCGCCATCACGTCGTGGTGGCCAGCCGCGGCTACAGCCCCGCGCTCCTGCCCGAAGGCGTACGCGCCGTACGCCTGGAGCGCACCGAGCCCGACGCCTACACCAGGCTGGTCGCCGCCGAAAAGCCCGACGCCGTGATCGATCTGACCTGCCACGACGCCGCGGACGCGGCGGTCACCCTGCGGGCCTGCGCCGGGGTCGACCGCGTCGTGGTCGTCTCCTCGGTGACGGCCGCCGGGCCCGCCACCACCACTCCGGTCACCGAGGCGACAGCGGCACCGCCGCTCTCCGAGTACGGCATCGACAAGCTGGCCGTCGAGGAGACGGTGCGCGCCGCCTGGGCGGACGGCACCTCCCAGGCCCTGCTCGTGCGCCTGGGCGCGGTCTACCGGCTCGGCGCGGATCTGGACGGCCAACTCGCCGAGGACGGCTGCTGGCTGGCGCACGCGGCGGCCGGAGCGCCTGCCGTGCTCGCCGACGACGGCGCGGCGCGGTGGAACCTGCTGCACGCCGACGACGCGGGCGCCGCACTCGCCGAACTGCTGGCCAACGACCGCGCTCGCGGCGTCCTGGTCCACCTGGCCTCCCGGCATCCGCTGCCCTGGCGCGAGCTGTACGAGCGGGTCCACCACGCGCTCGGACGCCCCTTCAACCCGGTTTCCGTACCCGCGGAGTGGGCCGCCGAGCAGCTGGAGGACGCCGAGTTCCTCGCCGAGACCTCCCGCTGGGACCAGGTCTTCGACCTCGGCCTGCTCGACCGGCTCGCGCCGTCCTACCAGGAGCGCGGCGGACCGTCGCGCGTCACCGAGGTCGCCCTGTGGCTGATCCGCCAGGGGCGCGTCGGGGACGCGGAACTCGGCGCGGAGATACAGGAGTTGCCCGCGCGCCTCGCGGCCGTGCGCACCGCGCCAGGGCTGGTGTGA	MSSQLALRGPELSANLCKPEEDTLRVLVTGGSGNVGVGVVRALNAARHHVVVASRGYSPALLPEGVRAVRLERTEPDAYTRLVAAEKPDAVIDLTCHDAADAAVTLRACAGVDRVVVVSSVTAAGPATTTPVTEATAAPPLSEYGIDKLAVEETVRAAWADGTSQALLVRLGAVYRLGADLDGQLAEDGCWLAHAAAGAPAVLADDGAARWNLLHADDAGAALAELLANDRARGVLVHLASRHPLPWRELYERVHHALGRPFNPVSVPAEWAAEQLEDAEFLAETSRWDQVFDLGLLDRLAPSYQERGGPSRVTEVALWLIRQGRVGDAELGAEIQELPARLAAVRTAPGLV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	53.17	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000704.1|Kanamycin_34 # 36389 # 37222 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=9bp;gc_cont=0.685	BGC0000704.1|Kanamycin_34 	36389	37222	+	Loose	500	264.233	sgm	53.16	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGTCGCAGTCCGCGTCCGACGAGGACCCCAAGTTAACGCGAGTCGTGGAGGCGGTCCGGGGCGGCAGGCGGTATCGGAGCGTGACCGACCAGGCCGTTCGCCGACTGGCCAGAGCGGCACTCGCTGTGGAGGGCGGCGACGTCACCAGGGCCACCAAGCGGACCAAGCGCGGACTCCACGAGGTCTTCGGCGCCTTCATGCCGATGACGCCCAAGTACGAGGCGCTGCTGCGCGATGTGCGGGAGGCCGTCGAGCTCGATGACCCGGAGGCGATCCGCACCGCCCTGAAACCCGCCCTCGGCGCCCACTCCTCCACCAGGGAGCGGCTCCCCATCCTCACGGAAATGTACGCCGAGGTCTTCGACCGCCTCGACACCGCCCCCGCCACCGTGCGCGACCTGGCCTGCGGGATGAACCCGCTGACCGTCCCCTGGATGCCGCTGCCCGCCGGGACGACCTACCTCGCCTCCGACATCGACCACCGTCTGATGGACTTCGCGGGAACGGTGCTCACCGCTCTCGGAGTCCCCAACCGGGTAGAGGTGCGGGACCTGTTGACGGACCCGGATCCCGAACCGGCCGACGTCACCTTCCTGTTCAAGGCCGTCCCCTGCCTTGAGGCACAGGGCAAGGGCCTCGGCTGGAAGCTGCTCGACCAGATCAATTCCCCCGTCCTGGTGGTGAGTTTCCCCACCAAGACCCTGGGCCGCCGCTCCAGGGGCATGTACCAGACCCATTCCGCGGAATTCGCCCGGCGCGTCGCCGAACGGCCCTGGAAGTGCGACGAGATCGAGTTCGGCGACGAACTCGTCTACGTGGTCACGAAGGGCTGA	MSQSASDEDPKLTRVVEAVRGGRRYRSVTDQAVRRLARAALAVEGGDVTRATKRTKRGLHEVFGAFMPMTPKYEALLRDVREAVELDDPEAIRTALKPALGAHSSTRERLPILTEMYAEVFDRLDTAPATVRDLACGMNPLTVPWMPLPAGTTYLASDIDHRLMDFAGTVLTALGVPNRVEVRDLLTDPDPEPADVTFLFKAVPCLEAQGKGLGWKLLDQINSPVLVVSFPTKTLGRRSRGMYQTHSAEFARRVAERPWKCDEIEFGDELVYVVTKG	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	101.09	gnl|BL_ORD_ID|1952|hsp_num:0	2079		
BGC0000704.1|Kanamycin_35 # 37305 # 38549 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.721	BGC0000704.1|Kanamycin_35 	37305	38549	+	Loose	700	47.3654	LpsB	24.66	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGCGTACTCCGGCTCACCCCGTTCTACCACCACGACTGTGTGGACAGCTGGCCCGCCGAGTTCGACGCGGTGGGCGGCATGCAGGTACAGATCCTGCGGATGTCCCGCGCCCTGGCCGAGTTGGGGGTGCGCCAGCAGGTGCTCACCGTCGGCTTCCCCGGTCTGCCCAGAGTGCGGCGCGACTCCGAGAACCTGGTGGTGCGGATCACCAGGGCCCCGCTGCCCAGGCTGCGCTCCAGGATCACCGGCCTGGTCGGCCTCAACCAGGCGTGGCTGGCCGCCGCGCTCACCGAATGCGTGAAACTGCGGCGCCGCTGGCCCGCCGACCTGATCCAGGTCCATCTGGACGGCCAGCTCTGGGCGTTGCTCGCGGGACCGGTCGCCGCCCGCCTGGTGGGCGTGCCGTACACGGTCACCGTGCACTGCTCGCGGCTGGCGGTGTATCAGCCCATGTCCACCGTCGACCGCATCCAGCACCCCTTGGTGACCGCCGTCGAGCGCTGGGCGCTGCGCCGTGCGGCCGGGATCACCACGCTGACCGAGCGGACCGCCACGGTGCTCGCCGCCGAACTGGGCGCGGCCCAGAGGGTGATCGACGTGGTGCCCGACGCGGTCGACCCCGATCGGGCCGAGGCCGCGCCCGCCGAGGTCGAGCGGCTGAAGAAGCGTTTCGGCCTGCCGCAGGAGGGCGGTCCCGTCATCGGATTCGTCGGCCGGATCGCCCACGAGAAGGGCTGGCGCCACGCCGTCCAGGCGGTGGCCGAACTCGCGGACGCGGGCCGGGACTTCACCTTCCTCGTCGTCGGAGACGGACCGCAGCGGGCCGACATGGAGGCGGCGGTGGCCGAGGCCGGTCTCACCGACCGGTTCGTCTTCACCGGGTTCCTGCCCAACGACGAGATCCCCGCCGTGATGACCGCCCTGGACGTCCTCCTGATGCCGTCCGTGCACGAGGAGTTGGGCGGCAGCGCCGTCGAGGCCATGCTCGCGGGAACGCCGGTGGCCGCCTACGGGGTCGGCGGCCTGTGCGACACCGTGGGCAAGGTGACCCCGTCCTTGCTGGCCGCGCCCGGCCAGGTGGCCGAACTCGCGCGGACGGTCAAGCGGGTACTCGACGATCCCGCGCCGGTCCTGGCCGAATTGCGTGCCGGACGGGAGTGGCTCGCGGACGAGTTCGGTGTCCACCACGCGGCCGGTCTCGCGTTGGCCCACTATGAGCGGGTACTCGGCAAAGAACGGTAG	MRVLRLTPFYHHDCVDSWPAEFDAVGGMQVQILRMSRALAELGVRQQVLTVGFPGLPRVRRDSENLVVRITRAPLPRLRSRITGLVGLNQAWLAAALTECVKLRRRWPADLIQVHLDGQLWALLAGPVAARLVGVPYTVTVHCSRLAVYQPMSTVDRIQHPLVTAVERWALRRAAGITTLTERTATVLAAELGAAQRVIDVVPDAVDPDRAEAAPAEVERLKKRFGLPQEGGPVIGFVGRIAHEKGWRHAVQAVAELADAGRDFTFLVVGDGPQRADMEAAVAEAGLTDRFVFTGFLPNDEIPAVMTALDVLLMPSVHEELGGSAVEAMLAGTPVAAYGVGGLCDTVGKVTPSLLAAPGQVAELARTVKRVLDDPAPVLAELRAGREWLADEFGVHHAAGLALAHYERVLGKER	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	113.11	gnl|BL_ORD_ID|2840|hsp_num:0	3793		
BGC0000704.1|Kanamycin_36 # 38722 # 39615 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000704.1|Kanamycin_36 	38722	39615	+	Loose	1190	35.4242	novA	23.87	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGGTCGGGGTCGATCGCGGCCGGTGGACCTGCGTCCTGGACTCCGACCCCGAGAGCCGGATCACCGCGATGCGCGCCCGCGAACTGGGCCGCAAGTCGGCGGTGATAGGCGACCGCGTCGACGTGATCGGCGACCTGTCCGGCAAGCCGGGCACCCTGGCCCGCATGGTCCGGGTCGCCCGGCGCGACAGCGTCCTGCGGCGCACCGCCGACGACACGGACCCCTACGAGCGGGTGGTGGTCGCCAACGCGGAACAGCTGGTGATCGTCTGCGCGTTGGCGGCGCCGCAGCCGCGCGCCGGTTTCATCGACCGTGCCCTGGTGGCGGCCTACGCGGGCGGTCTGCGGCCGGTGCTCTGCCTGACCAAGGCGGACCTGAAGGGCCCCGAGGACGTGGTGAGCACCTACGCCCATCTGGATCTGCCGATCGTGGTCACGCGCTCCGACCGCGCCCCGGACGCCCTGCGCGAGCAGCTGGCCGGGCGCGTCTCGGCCCTGGTCGGACACTCCGGAGTCGGCAAGTCCACGCTGATCAACATCCTGATCCCGCAGGCCCGGCGGGTCACCGGTGAAGTGAGCGCGATCGGGAAGGGCCGCCACACGTCCACCTCGGCCGTCGCCCTGCCGCTGCCGGACGGCGGCTGGGCCGTGGACACCCCCGGCATCCGCTCCTTCGGGCTTGCCCACGTCACGTCCGACGACGTCCTCGACGCCTTCCCCGACCTGAGCGACGGCGCGGAGGACTGCCCGTCCGGCTGCCGTCATCTGGGCGCCCCGCACGACTCGGGATGCGGCCTGGAGCGCCTGAGCGAAGCCGATCCGGCCAGGGCGCGGCGGCTGGAGTCGCTGCGCCGCCTGCTGCGCTCGCACGCGGGCATCGAAGAGGAGTGA	MVVGVDRGRWTCVLDSDPESRITAMRARELGRKSAVIGDRVDVIGDLSGKPGTLARMVRVARRDSVLRRTADDTDPYERVVVANAEQLVIVCALAAPQPRAGFIDRALVAAYAGGLRPVLCLTKADLKGPEDVVSTYAHLDLPIVVTRSDRAPDALREQLAGRVSALVGHSGVGKSTLINILIPQARRVTGEVSAIGKGRHTSTSAVALPLPDGGWAVDTPGIRSFGLAHVTSDDVLDAFPDLSDGAEDCPSGCRHLGAPHDSGCGLERLSEADPARARRLESLRRLLRSHAGIEEE	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	48.29	gnl|BL_ORD_ID|1140|hsp_num:0	1210		
BGC0000704.1|Kanamycin_37 # 39650 # 40048 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=3bp;gc_cont=0.712	BGC0000704.1|Kanamycin_37 	39650	40048	+	Loose	750	25.7942	tet(50)	26.19	3004584	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCCGACTGACCCACATCAGCGCCCCCGAGGGCGTCGCCCCCGCCACCGCCTACACCCACGTCGTGATGGGCACGGGCCGATTCGTCGCGATATCCGGCCAGTTGGCCCTGGACGAGGACGGCAAGCTGGTCGGCGAGGGCGACGCGGCGGCGCAGGCCCACCAGGTCTTCGAGAACCTGCGGCGCTGCCTGACCGCGGCGGGCGCGACGTTCGACGACGTCGTGAAGCTGACGTACTTCGTGACGGACATGGCGCACATGCGGGCGATCCGCGGCGCGCGGGACGCCTTCCTTGACCCCGAGCGGCTGCCCGCTTCCTCGGCGGTGCAGGTGGGCGCGCTGGTCGCGCCCGAGTATCTGATGGAGATCGAGGCGTTCGCGGTGGTGGCCGAGTAG	MSRLTHISAPEGVAPATAYTHVVMGTGRFVAISGQLALDEDGKLVGEGDAAAQAHQVFENLRRCLTAAGATFDDVVKLTYFVTDMAHMRAIRGARDAFLDPERLPASSAVQVGALVAPEYLMEIEAFAVVAE	MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE	34.02	gnl|BL_ORD_ID|2780|hsp_num:0	3287		
BGC0000704.1|Kanamycin_38 # 40072 # 40743 # -1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=4bp;gc_cont=0.746	BGC0000704.1|Kanamycin_38 	40072	40743	-	Loose	500	25.7942	chrB	48.48	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGCCCCGCTCACATGAGATTAACCGGCGAGTAACGAGCGCGCCAGCCCTCAGTGTTTGTGATCTACGTCGCCGGGAGGGATCGGCGGTTAGGCTCGCGGCCATGGATGAGGAGTTGCGGACGGTGACGGAACGTTTACGCGCCGAGGCGGGGGGCTCGAAGGAGTACGAGCGGCTGGTCGCGACCGGTGACCTCGAGGAGCTCGCCGAGGTGCTCGTCTCGCCGGAACAGCCCTTGTGGACAAGGGAGTTGGCGGCGGTCCTGCTCGGCGTCGCCGGGGACCGCCGGGCCTTGGAATCGCTCGTCCTGCTCCTCAACCACCGGGACGCGCCGCGCTGCGCGGCGGCGGCGTACGCCCTGGCCAGGCTCGGCGACCCCCGCACCGCGCGCGCGGCGGCCGCCCTGGCGACGAACGAACTCCGCGTCGCCTACGCCCTGCACCCGGTGCGCCTCCTGACGGAGCTGCGCGCCCCGGAGTCGGCGCCCGCGCTGATCACGACGCTGCGGCGGCGCCTCGCCCCGCACGACCCGTTCGGCAAGATCGCGCTCGCCTGTGTGGAGGGCCTGGGCGCGCTCGGGGACCCCCGGGCGAGACCGGTGCTGACCGCGGCGCGGGCCCATCCCCGCCTCGCGGCGGCGGCCTCGGCGGCCCTGGCGCGGCTGCCGGAGTGA	MPRSHEINRRVTSAPALSVCDLRRREGSAVRLAAMDEELRTVTERLRAEAGGSKEYERLVATGDLEELAEVLVSPEQPLWTRELAAVLLGVAGDRRALESLVLLLNHRDAPRCAAAAYALARLGDPRTARAAAALATNELRVAYALHPVRLLTELRAPESAPALITTLRRRLAPHDPFGKIALACVEGLGALGDPRARPVLTAARAHPRLAAAASAALARLPE	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	79.64	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0000704.1|Kanamycin_40 # 42890 # 43702 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000704.1|Kanamycin_40 	42890	43702	+	Loose	400	44.669	cmeR	34.38	3000526	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidic acid	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCAAGGCCGCCAAGTCCTCACGCAACGCCAGCCCCGACGCTCCGGAGAGCGCCGCGGGCAGCCGTGCCGCCGCCCAACGCCTCAAGATGCGCAGGGAGCTGGCTGCGGCGGCCATGGAGCTCTTCGCGACCAAGGGGTACGAGGCGACGACGGTCGACGAGATCGCCGCCGCCGCGGGCGTCGCCCGCCGGACCTTCTTCCGGCACTTCCGCTCGCAGGAAGAGCCGATCTTCCCCCGACACGACGACACCCTGGTCCGCGCGGAGGAGGTGCTGAACGCCGCACGGGCGCACGAGCAACCGCTCGACACGGTGTGCCGCGGCATCAAGGAAGTCATGAAGATGTACCCGGCCTTCCGCCCGCGGTTCTCCGTGGAGCGCTACCGGCTGACCCGTGAGGTGCCCACGCTGCGCGAGCGCGAGATCGCCTCCGTGGCCCGCTACGAACGGCTGTTCACGCGGTATCTGCTCGGCCACTTCGATGAGCAGGCGCACCACGACGGCAACGACGACCCGCTGCTCGCCGAGGTCGCCGCCTCCGCGGTGGTCACCGCCCACAACCACGTCCTGCGCCGCTGGCTGCGGGCGGGCGGCCAGGGCGACCTGGAGGCCCACCTGAACCACGCGTTCGGCATCGTCCGGCTCACCTTCGGCACCGGGATCGGCGCGGGCCGCTCCTCGGCACCGGCCACCGCCCCCGCCACGGTCTCCGCGCAGGGCGAGGTCCTGGTCACCGTGGCCCGTACGGACGCGCCGCTCGACGAGGTCATGCGGACGATCGAGAAAGCCCTCCGCGAGCGGGCCTCATAG	MSKAAKSSRNASPDAPESAAGSRAAAQRLKMRRELAAAAMELFATKGYEATTVDEIAAAAGVARRTFFRHFRSQEEPIFPRHDDTLVRAEEVLNAARAHEQPLDTVCRGIKEVMKMYPAFRPRFSVERYRLTREVPTLREREIASVARYERLFTRYLLGHFDEQAHHDGNDDPLLAEVAASAVVTAHNHVLRRWLRAGGQGDLEAHLNHAFGIVRLTFGTGIGAGRSSAPATAPATVSAQGEVLVTVARTDAPLDEVMRTIEKALRERAS	MNSNRTPSQKVLARQEKIKAVALELFLTKGYQETSLSDIIKLSGGSYSNIYDGFKSKEGLFFEILDDICKKHFHLIYSKTQEIENGTLKEILTSFGLAFIEIFNQPEAVAFGKIIYSQVYDKDRHLANWIENNQQNFSYNILMGFFKQQNNSYMKKNAEKLAVLFCTMLKEPYHHLNVLINAPLKNKKEQKEHVEFVVNVFLNGINSSKA	128.57	gnl|BL_ORD_ID|1161|hsp_num:0	1232		
BGC0000704.1|Kanamycin_41 # 44100 # 45410 # 1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.676	BGC0000704.1|Kanamycin_41 	44100	45410	+	Loose	660	40.817	MexS	23.89	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGAAATCCTGGACGCGATTCAGTCGCAGGACGCACAGTCCGCCGACTTCGCCGCTCTCCCCCTGCCCGACTCGTACCGCGCGATCACCGTGCACAAGGACGAGACGGAGATGTTCGCGGGCCTGGACACCCGCGACAAGGACCCCCGCAAGTCCCTCCACCTGGACGACGTGCCGGTGCCCGAACTCGGCCCCGGTGAAGCCCTGGTGGCCGTGATGGCCTCCTCGGTGAACTACAACTCCGTGTGGACCTCGATCTTCGAGCCGCTGTCGACCTTCGGCTTCCTGGAGCGCTACGGCAAGGTCAGCGAGCTCACCAAGCGCCACGACCTGCCGTACCACGTCATCGGCTCCGACCTGGCGGGCGTCGTGCTGCGCACCGGGCCCGGCGTGAACTCCTGGAAGCCGGGCGACGAGGTCGTCGCGCACTGCCTGAGCGTCGAGTTGGAGTCGAGCGACGGCCACAACGACACGATGCTCGACCCCGAGCAGCGCATCTGGGGCTTCGAGACGAACTTCGGCGGCCTCGCCGAGATCGCGCTCGTCAAGTCCAACCAGCTCATGCCCAAGCCGGGCCACCTGAGTTGGGAGGAGGCCGCCGCTCCCGGGCTCGTGAACTCCACCGCGTACCGCCAGCTCGTCTCGCGCAACGGCGCCGACATGAAGCAGGGCGACAACGTGCTGATCTGGGGCGCGAGCGGCGGACTCGGCTCCTACGCCACGCAGTTCGCGCTCGCCGGCGGCGCCAACCCGATCTGTGTGGTCTCCAGCGAGCAGAAAGCCGACATCTGCCGCTCCATGGGCGCCGAGGCGATCATCGACCGCAGCGCCGAGGGCTACCGGTTCTGGAAGGACGAGCGCACCCAGGACCCCAAGGAGTGGAAGCGCTTCGGCAAGCGCATCCGCGAGTTCACCGGCGGCGAGGACATCGACATCGTCTTCGAGCACCCCGGCCGCGAGACCTTCGGCGCCAGCGTCTACGTCACCCGCAAGGGCGGCACCATCACCACCTGCGCCTCCACCTCGGGCTACATGCACGAGTACGACAACCGCTACCTGTGGATGTCCCTCAAGCGCATCATCGGCTCCCACTTCGCCAACTACCGCGAGGCCTGGGAGGCCAACCGCCTGATCTCGTCAATGACCGCACTCGGCCGCGTCGACGCGGCCGTGGTTGAGCCCGTCGTACAACGCGCCGTGCCCACGCCGATGTTCGGTTCTCGCAGAGCATCGCGTCGCAGAGCTCGAACAGGGTGTCACCTCGCCGGGGCAGGCGCGCGTAGAAGTCCTCCCGAAAGTGGGACGTGA	VKEILDAIQSQDAQSADFAALPLPDSYRAITVHKDETEMFAGLDTRDKDPRKSLHLDDVPVPELGPGEALVAVMASSVNYNSVWTSIFEPLSTFGFLERYGKVSELTKRHDLPYHVIGSDLAGVVLRTGPGVNSWKPGDEVVAHCLSVELESSDGHNDTMLDPEQRIWGFETNFGGLAEIALVKSNQLMPKPGHLSWEEAAAPGLVNSTAYRQLVSRNGADMKQGDNVLIWGASGGLGSYATQFALAGGANPICVVSSEQKADICRSMGAEAIIDRSAEGYRFWKDERTQDPKEWKRFGKRIREFTGGEDIDIVFEHPGRETFGASVYVTRKGGTITTCASTSGYMHEYDNRYLWMSLKRIIGSHFANYREAWEANRLISSMTALGRVDAAVVEPVVQRAVPTPMFGSRRASRRRARTGCHLAGAGARRSPPESGT	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	128.61	gnl|BL_ORD_ID|1067|hsp_num:0	1041		
BGC0000704.1|Kanamycin_42 # 45501 # 45983 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.663	BGC0000704.1|Kanamycin_42 	45501	45983	+	Loose	300	25.409	APH(3')-IX	20.51	3004087	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGCGAGGGCCGTCCGCCTGTCCCGCGCCCCCCCCGGTGAGTGACTCAGTTCGGAACCTGTTCGACCCCGGCATGCATGATGGGGCAGTGAACTGGACCTCATCGGGCAACGCCGTCGTGGAAGCCGGTTGGCAGACGGTAAGGGACGACGGACGCGTACGCGCCGAACTCCTCGAAGCGGCCTACGCAGAGCCGCGCCTACGGCAGTTGTTCCCCTGGACGGGGATGGGCGAGCTGCACTTCAGCCGCTGCACAGAGTGGCGGCACACCTGGGACATTCCCTACATCCAGCCCGCAGCCGAAGGCGCCTACTGGGTCTCCGGACCTCTCCGCACTGACACGGTGGGCTCGGCGGCCACAGCGCAGGAGGCCATCGCCATGGTGGTCGAACGCCTTCCAGCACGCTGTGGCCCCGCATTCGTCGGAACACCAGAAGAACTCACAGCTCACGAAGCTGCAACGCGGAAAACGCAGTCGGACTGA	MRGPSACPAPPPVSDSVRNLFDPGMHDGAVNWTSSGNAVVEAGWQTVRDDGRVRAELLEAAYAEPRLRQLFPWTGMGELHFSRCTEWRHTWDIPYIQPAAEGAYWVSGPLRTDTVGSAATAQEAIAMVVERLPARCGPAFVGTPEELTAHEAATRKTQSD	MINDMKISLPQSLKSFIGNQPLQKDKVGQSPSDVYSFTKNNEKYYLKTTELIYAQTTYSIIREAKILDWLDGKLNVPELVLMDTDHENEYMISKAVPAKPLQDFTGKSDQFFIDIYTDALAQLQSISIKNCPFISNKKFRLAEAEFFIENGLLDELDDDEKDLKLWSSYQNFAEFLDDLKQQNFQEEYVFSHGDLTDSNVFLSHDAQIYFLDVGRAGIADRFVDIAFIERSLREDCSEDAALQFLNHLAEDDSFKRNYFLKLDELN	60.15	gnl|BL_ORD_ID|2445|hsp_num:0	2751		
BGC0000704.1|Kanamycin_43 # 46353 # 46622 # -1 # ID=1_43;partial=00;start_type=GTG;rbs_motif=GGCGG;rbs_spacer=14bp;gc_cont=0.681	BGC0000704.1|Kanamycin_43 	46353	46622	-	Loose	500	23.8682	erm(46)	46.15	3004596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCGCGGCGTGAACAACCTCGCGATTCGATCTCTTAGCGCCCTCGCACCCGTCCTGGCCTTCGGGCTGGCATCACCGGCGACGGCTGCCGCCGACCCGTCACCGTCCCTCTCCGCGCTGTGGGAGAACGCCGTTCCTGAGAACGCGGCCGCAGTCCGGTGCGGCGACGTGACACTCAACGCCGATGCCGCTCCATGCATCGTCTCGGCATGGGCGGCCACTCTCGCAGGGCAGGCCTACCGCGGCACGTGTCTGCCAGATCCTTCCTAG	MRGVNNLAIRSLSALAPVLAFGLASPATAAADPSPSLSALWENAVPENAAAVRCGDVTLNADAAPCIVSAWAATLAGQAYRGTCLPDPS	MPTYRSGRHELGQNFLTDRKAVDTIVDLVSRTDGPIIEIGSGGGALTLPLQALRRPITAIEIDPRHVQKLQHRVDPSTTVVHGDFLRYRLPRTPHTIVGNLPFHHTTAMLRRILHAEHWTASVLLVQWEVARRRAAVGGATMMTAQWWPWYDFGLAGRVSASAFTPRPGVDAGLMTIARRTVPLVDPALRPRYSTFVHTVFTSKGHGLHQILPRVAGDPEKAAVKKWLAGQRFRGTPLPRDLSPGQWSELFAIIDRRSPATDRKRAEYRR	32.96	gnl|BL_ORD_ID|2789|hsp_num:0	3297		
BGC0000704.1|Kanamycin_44 # 46679 # 47050 # -1 # ID=1_44;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000704.1|Kanamycin_44 	46679	47050	-	Loose	1000	23.483	lsaA	48.0	3000300	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGACCTGTCGATCGACATCCGCTGGCTCCTGGAACGCCAGGCCGAGCTCCTGCCCAAGCAGCCAGAGATCCACGACTTCTCCAGCCTCGTCGCCGCGGTCGCCAAACACCGCGTCAACACCCCGCAGATCGGCACCGTCCCCGATAACTCGTGGCGCGCCGCGGCCCTGATGTACGCCCTCACCCGCCTGCGCCCGCTCCCGGCCCGCAACGCCCTGTACGGCGTCGGCATCGCCACCGCCTACATGAGCGCCGCGGGCGAGGCCATCGACCCGCCCTACGGCGCTCTCGTCGACCTCGCACGCGACATCGACACCGGCCGCGCCGACACGTACGACACAGCCGACCGCATCCGCTCCTGGCGGATCTGA	MDLSIDIRWLLERQAELLPKQPEIHDFSSLVAAVAKHRVNTPQIGTVPDNSWRAAALMYALTRLRPLPARNALYGVGIATAYMSAAGEAIDPPYGALVDLARDIDTGRADTYDTADRIRSWRI	MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS	24.70	gnl|BL_ORD_ID|1227|hsp_num:0	1298		
BGC0000704.1|Kanamycin_26 # 29519 # 29635 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.778	BGC0000704.1|Kanamycin_26 	29519	29635	+	Loose	500	21.1718	Mycobacterium leprae folP with mutation conferring resistance to dapsone	55.56	3003389	protein variant model	T53P	n/a	sulfone antibiotic	antibiotic target alteration	dapsone resistant dihydropteroate synthase folP	GTGACGGCGGCGCCACGGGACCTGGTCGACGCGGTGGTCGACGAACTCGCGGAACCCCCACGGCCCGCGGCCGCGAGGACCGACGACGCCGCCACCGTCCTCGGCGGTGCCGGGTGA	MTAAPRDLVDAVVDELAEPPRPAAARTDDAATVLGGAG	MSLAPVQVIGVLNVTDNSFSDGGRYLDPDDAVQHGLAMVAEGAAIVDVGGESTRPGAIRTDPRVELSRIVPVVKELAAQGITVSIDTTRADVARAALQSGARIVNDVSGGRADPAMAPLVAEAGVAWVLMHWRLMSAERPYEAPNYRDVVAEVRADLLAGVDQAVAAGVDPGSLVIDPGLGFAKTGQHNWALLNALPELVATGVPILLGASRKRFLGRLLAGADGAVRPPDGRETATAVISALAALHGAWGVRVHDVRASVDALKVVGAWLHAGPQIEKVRCDG	13.38	gnl|BL_ORD_ID|2030|hsp_num:0	1721		
